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 Humans have lived at high altitude for hundreds of generations despite 
unavoidable challenges imposed by hypobaric hypoxia.  The lower barometric pressure at 
high altitude reduces the number of oxygen molecules available in each breath of air, yet 
oxygen-dependent physiological processes must be maintained for survival.  Cellular and 
system responses to hypoxic stress can result in altitude illness and may prove fatal in a 
small proportion of maladapted individuals.   
 Native high-altitude populations, however, exhibit a unique suite of heritable 
traits that afford tolerance to hypoxia.  Compared to lowland visitors and Andean 
highlanders, Tibetans exhibit lower hemoglobin (Hb) levels at high altitude, which tend 
to be similar to those expected under sea-level conditions.  Such differences suggest this 
population has unique adaptations to their native environment.   
 It has been hypothesized that genes specifically involved in the hypoxia inducible 
factor (HIF) pathway could underlie adaptive changes in high-altitude populations. 
Genome-wide analyses provide the first lines of evidence in support of genetic adaptation 
to high altitude.  Three regions of the genome that contain genes associated with the 
human response to hypoxia show evidence of selection and are associated with decreased 
Hb levels, and two of these are also associated with metabolite levels.  These phenotypic 
associations provide corroborative evidence for adaptive roles of genomic regions 
targeted by strong positive selection in Tibetans.   
iv 
 While many of the same selection candidate genes are reported by studies of 
different Tibetan populations, some signals of selection and association are unique to 
particular groups.  The genetic makeup of Tibetan groups located throughout the plateau 
is therefore important to consider in studies of high-altitude adaptation.  
 Taken together, the data presented in this dissertation demonstrate that multiple 
genes are involved in Tibetan adaptation to high altitude.  Some of these genes have been 
linked to hematological and metabolic phenotypes characterized thus far, providing 
further support for roles in physiological adaptation to this extreme environment.  Studies 
aimed to identify associations between specific genetic variants, mechanisms, and 
phenotypes will help bridge the gap between genetic variation and organismal responses 
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Overview of human adaptation to high altitude 
The decrease in partial pressure of oxygen at high altitude reduces oxygen 
availability and imposes extreme physiological challenges in humans (Beall, 2007).  
Cellular and system responses to this stress can result in altitude illness and may prove 
fatal in a proportion of maladapted individuals (Hackett and Roach, 2001; MacInnis et 
al., 2010).  Some highland populations, however, have adaptations that enable their 
successful existence in a hypoxic environment (Beall, 2007).   
Native high-altitude Tibetans exhibit a unique suite of heritable traits that afford 
tolerance to hypoxia (decreased oxygen tension) (Beall, 2000; Beall, 2007; Moore, 2001).  
Compared to lowland visitors and high-altitude native Andean groups, Tibetans living at 
high altitude exhibit elevated nitric oxide levels, increased resting ventilation and hypoxic 
ventilatory response, and greater birth weights at high altitude (Beall, 2007; Beall et al., 
1998; Moore, 2001; Wu et al., 2005).  They also have hemoglobin (Hb) levels similar to 
those expected at sea level (Beall, 2007; Beall et al., 1998; Moore, 2001; Wu et al., 
2005), which may prevent high blood viscosity caused by polycythemia (a typical 
response to hypoxia and a hallmark of chronic mountain sickness) (Monge, 1976; Vargas 
and Spielvogel, 2006), or result from changes afforded by an adaptive trait other than Hb 
level.  These physiological and pathological differences suggest that Tibetan populations 
possess unique adaptations that enable survival in their native high-altitude environment.   
Genomewide analysis of selection can provide unprecedented insight into the 
biological mechanisms of recent human evolution.  By combining novel genomic 
techniques with decades of physiological research, we now have the ability to begin to 
uncover the basis of high-altitude adaptation.   In addition to answering long-standing 
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questions in the field of high-altitude research, such studies will enhance our 
understanding of the human response to hypoxia, which has broad-reaching implications 
in medical research.  Overall, the goal of this dissertation is to understand the genetic 
basis of Tibetan adaptation to high altitude, and to determine whether selection candidate 
genes are associated with a subset of phenotypic measurements that provide biological 
insight into mechanisms of high-altitude adaptation.     
 
Genes related to the hypoxia inducible factor (HIF) gene 
pathway are likely involved in high-altitude adaptation 
The mechanisms underlying high-altitude adaptation are currently unknown but 
may be elucidated through identification of genetic factors that provide fitness 
advantages at high altitude.  Hypoxia-related genes are key regulators of fundamental 
physiological processes in mammals including red blood cell production (erythropoiesis), 
development, energy metabolism, vasculogenesis, iron metabolism, cardiopulmonary 
regulation, and tumor promotion (Majmundar et al., 2010; Semenza, 2010).  The hypoxia 
inducible factor (HIF) signaling cascade mediates the transcription of various genes in 
response to oxygen level and is central to mitigating the negative effects of cellular 
hypoxia.   
HIFs are heterodimeric transcription factors comprised of a constitutively 
expressed  subunit and one of three  subunits (Figure 1.1).  Two of the subunits 
(HIF-1 and HIF-2) play a central role in responding to hypoxia (Hirota and Semenza, 
2006; Yoon et al., 2006).  Under normoxic conditions, the  subunits are hydroxylated by 
prolyl hydroxylases (PHDs) and targeted for degradation through interaction with the von 
Hippel-Lindau (VHL) complex, although other factors are also involved in this regulation 
  4   
 
Figure 1.1: Overview of the hypoxia inducible factor (HIF) pathway. Degradation of HIF 
α subunits under normoxic conditions requires O2, proline hydroxylase activity, iron, and 
VHL and is regulated by PHD and FIH.  Under hypoxic conditions, HIF α subunits are 
not hydroxylated and are able to heterodimerize with the HIF  subunit, forming the 
active transcription factors HIF-1 and HIF-2. These factors bind with p300 and CBP 
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(Kaelin and Ratcliffe, 2008; Majmundar et al., 2010).  Under hypoxic conditions, the  
and  subunits dimerize and transcribe HIF-regulated genes.  Mutations identified in 
HIF-pathway genes, including VHL, EGLN1/PHD2, and EPAS1/HIF2A, are associated 
with congenital and/or hereditary erythrocytosis (Semenza, 2009), and misregulation of 
HIF pathway members has been shown to have metabolic consequences in humans 
(Formenti et al., 2010).  
 
Genomic regions under strong selection contain  
genes likely involved in adaptation to high altitude in Tibetans 
 It has been hypothesized that genes specifically involved in the HIF pathway 
could underlie adaptive changes in high-altitude populations (Beall et al., 1998; Bigham, 
2009; Moore, 2001; Rupert, 2010; Rupert and Koehle, 2006).  However, prior to the 
advent of high-density genotyping platforms, it was difficult to test whether genetic 
factors were involved in high-altitude adaptation beyond examination of a limited set of 
candidate genes.  It is now possible to conduct “population genomic” studies to determine 
informative patterns of genetic variation, such as those characteristic of a selective sweep, 
on a genome-wide scale (Figure 1.2) (Stinchcombe and Hoekstra, 2007).  These powerful 
methods identify outlier regions of the genome that may be further examined to 
determine the exact genetic variant targeted by natural selection.    
To test whether natural selection has acted on specific genes associated with high-
altitude adaptation in Tibetans, we performed two genome-wide haplotype-based tests of 
selection: iHS (Voight et al., 2006) and XP-EHH (Sabeti et al., 2007).  These statistics 
identify regions of the genome that exhibit a striking signal of haplotype homozygosity   
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Figure 1.2: Illustration of a selective sweep.  Over time, a selected variant and its 
surrounding linked regions will increase rapidly in a population, leaving a strong signal 
of haplotype homozygosity, the signature of a selective sweep.  A selective sweep may be 
identified in the incomplete stage (middle pane) using iHS (Voight et al., 2006) and 
nearly fixed or fixed selection events using the cross-population comparison XP-EHH 
(Sabeti et al., 2007).  These tests identify regions of the genome that harbor the 
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that results from a rapid increase in the frequency of selected variant(s) and their 
neighboring polymorphisms (Figure 2).   
The development of these analytical methods has shed new light on adaptation in 
Tibetans and the field of high-altitude research.  First, our studies and many others 
(Bigham et al., 2010; Peng et al., 2011; Wang et al., 2011; Xu et al., 2011; Yi et al., 
2010) indicate that many genes are involved in this process, suggesting that various 
genetic factors act in concert to provide an advantage to Tibetans.  Second, the results of 
the research presented here and other recent studies suggest that many selection targets 
are similar in various Tibetan groups while others appear to be heterogeneous among 
populations (Chapter 5).  Therefore, the idea that many genetic factors are involved in 
high-altitude adaptation is supported by several recently published reports of the same 
selection candidate genes despite different Tibetan samples and analytical strategies.  
 
High-altitude selection candidate genes are  
associated with hypoxia-related phenotypes 
While decades of research efforts have focused on physiological differences 
among native high altitude populations (Beall, 2007), evidence for an underlying genetic 
basis was lacking until this past year.  To determine whether the selection candidate 
genes identified were associated with trait variation in Tibetan highlanders, we compared 
selected haplotypes to hematological and metabolic phenotypes.  We found that the 
selection candidate regions containing EGLN1/PHD2 and PPARA genes are associated 
with hemoglobin (Hb) concentration in a population from the Tibetan village of Maduo 
(4250 meters), and selection candidates EPAS1/HIF2A and PPARA are associated with 
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lactate and free fatty acid levels, respectively, in individuals from the Tuo Tuo River 
Tibetan village (4350 meters) (Figure 1.3).   
In order to determine whether we could detect the same selection candidate 
regions and association signals in a population located in a different region of the Tibetan 
Plateau, we set out to collect samples from a second high-altitude population.  While 
several of the same selection signals were detected, none of the selection candidate genes 
were associated with hemoglobin levels in the second group.  We did, however, observe a 
nonsignificant trend between the EPAS1/HIF2A selection candidate gene haplotype and 
Hb level in our second population.   Recent work from other groups identified an 
association between this particular selection candidate and hemoglobin level (Chapter 5) 
(Beall et al., 2010; Yi et al., 2010), suggesting similarity between these Tibetan groups 
and the Tuo Tuo River sample we studied (Figure 1.3).  Furthermore, associations 
detected between selection candidates and metabolite levels in the second population are 
not observed in the Maduo population, although the sample size was limited for this 
comparison (n = 20) (Chapter 3).  These results suggest there may be differences among 
Tibetan groups and motivate efforts to further characterize the genetic and phenotypic 
differences in various Tibetan groups (Chapter 5).  
Despite limited sample sizes used for our two population studies, the signals are 
apparent.  While there are various statistics that may be used to detect signals of positive 
selection on a genomewide scale (Akey, 2009), we chose to use the two most powerful 
methods to identify incomplete and complete selective sweeps for genomewide SNP data 
in the absence of a calibrated model of demographic history.  It is unclear, however,   





Figure 1.3: Sample locations for two Tibetan populations examined.  The Maduo sample 
(~4,250 meters), collected in 2009, are Amdo Tibetan, and the Tuo Tuo River sample 
(~4,500 meters), collected in 2010, are Kham Tibetan.   
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if larger samples would afford more variation to test for genotype-phenotype 
relationships.  Regardless, we have identified striking signals between selection candidate 
regions different phenotypic traits in these populations.   
 
Population variation within Tibet 
While non-overlapping selection and association signals observed in Tibetan 
population could reflect differences in analytic strategies and statistical power, they could 
also indicate that different loci have been selected in different high-altitude populations.  
To test whether we would observe differences among selection signals and phenotype 
associations using the same analytical strategies, we collected and performed the same 
analyses in two Tibetan populations located in different regions of the Qinghai-Tibetan 
Plateau.   
The two populations studied are geographically distinct from each other and 
speak different dialects (Amdo Tibetan in the village Maduo and Kham Tibetan in the 
Tuo Tuo River location; Figure 1.3).  We determined that many of the same loci are 
under selection in these distinct Tibetan populations and determined that some signals are 
unique, suggesting that these populations have either acquired different mechanisms to 
adapt to high altitude, exhibit signals presently evident in one population but potentially 
diminished/non-existent in the other (possibly due to timing of the selection event and 
consequent breakdown of linkage disequilibrium), or false positive signals. 
Despite the unknown reasons for differences at this time, we were able to 
conclude from this work that many selection signals are similar among Tibetan 
populations from different regions of the Tibetan Plateau.  The additional support 
provided by studies conducted by other research groups suggests that these selection 
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targets could have important relationships with as of yet unmeasured phenotypes vital to 
survival in populations throughout the Qinghai-Tibetan Plateau.  These selection 
candidate regions will be prioritized in future efforts to characterize precise genetic 
variants and their biological roles in adaptation in highland populations (Chapter 5). 
 It is clear that evolutionary processes have affected specific hypoxia- and 
metabolism-related genetic factors in high-altitude Tibetans.  The associations between 
several of the selected candidate genes and a decreased hemoglobin phenotype provide 
supporting evidence for functional roles of genetic variants specific to high-altitude 
Tibetans.  While these studies provide a step forward in the field of high-altitude 
research, they also raise many questions regarding the mechanisms involved in human 
adaptation to hypoxia.  In order to understand this process, it will be necessary to 
integrate these recent genetic advances with current knowledge of relevant molecular 
pathways and the many physiological insights afforded by decades of high-altitude 
research.  Once the precise genetic variants are identified, functional analysis is necessary 
to elucidate the precise mechanisms underlying hypoxia tolerance.   
 Future studies will also help to elucidate whether some variants within these 
genes contribute to maladaptive responses that result from limited oxygen supply.  These 
consequences extend beyond altitude sickness and are relevant to clinical pathologies 
such as pulmonary hypertension, heart disease, stroke, tumor hypoxia, and metabolic 
disorders (Majmundar et al., 2010).  Further studies of high-altitude adaptation may allow 
interventions to reduce common, hypoxia-induced maladies suffered by lowlanders 
through identification of potential new targets for more common forms of clinical 
pathologies.   
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 In addition to physiological and molecular aspects of high-altitude adaptation, 
genetic studies of native high-altitude populations will provide valuable insights into 
evolutionary processes.  It remains to be seen how natural selection has orchestrated 
human biological changes and how much of this fine-tuning is based upon novel or 
standing genetic variation.  It will also be important to determine if and how the selection 
candidates, some of which have been reported in more than one study (Table 5.1), are 
involved in high-altitude adaptation and whether differences reported in selection and 
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Abstract 
 Tibetans have lived at very high altitudes for thousands of years, and they have a 
distinctive suite of physiological traits that enable them to tolerate environmental 
hypoxia.  These phenotypes are clearly the result of adaptation to this environment, but 
their genetic basis remains unknown.  We report genome-wide scans that reveal positive 
selection in several regions that contain genes whose products are likely involved in high-
altitude adaptation.  Positively selected haplotypes of EGLN1 and PPARA were 
significantly associated with the decreased hemoglobin phenotype that is unique to this 
highland population.  Identification of these genes provides support for previously 
hypothesized mechanisms of high-altitude adaptation and illuminates the complexity of 




The Tibetan highlands are one of the most extreme environments inhabited by 
humans.  Many present-day Tibetan populations are thought to be descendants of people 
who have occupied the Tibetan Plateau since the mid-Holocene, between 7,000 and 5,000 
years ago (Su et al., 2000), and possibly since the late Pleistocene, approximately 21,000 
years ago (Moore, 2001; Zhao et al., 2009).  Compared to Andean populations living in 
similar high-altitude conditions, Tibetans exhibit a distinct suite of physiologic traits: 
decreased arterial oxygen content, increased resting ventilation, lack of hypoxic 
pulmonary vasoconstriction, lower incidence of reduced birth weight, and reduced 
hemoglobin (Hb) concentration (on average, 3.6g/dl less for both males and females) 
(Beall, 2007; Chen, 1997; Ge, 1994; Ge et al., 2002; Groves et al., 1993).  Neighboring 
Han Chinese individuals and other nonadapted lowland visitors to high-altitude regions 
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develop increased Hb concentration to compensate for the hypoxic high-altitude 
environment (Wu et al., 2005), and this response is associated with adverse effects (Mejia 
et al., 2005; Vargas, 2006).  
 High-altitude Tibetans maintain normal aerobic metabolism despite profound 
arterial hypoxia (Beall, 2007), perhaps through the existence of changes in the oxygen 
transport system. For example, elevated circulating nitric oxide (NO) levels increase 
vasodilation and blood flow (Beall et al., 2001), which, when combined with increased 
ventilation (Zhuang et al., 1993), may increase the availability of oxygen to cells (Beall, 
2007). Collectively, these traits suggest strongly that Tibetans have adapted uniquely to 
extreme high-altitude conditions. The genetic basis of this adaptation, however, remains 
unknown.  
 
Materials and methods 
 
DNA sample collection  
DNA was extracted from whole blood samples for 49 individuals (non-smokers, 
no chronic diseases) residing in Madou County in Qinghai province (~4,350 m).  
Informed consent was obtained for all participants according to guidelines approved by 
the Institutional Review Boards at the High Altitude Medical Research Institute (Xining, 
Qinghai, People’s Republic of China).  
 
SNP genotyping 
Forty-nine individual DNA samples were genotyped using Affymetrix 6.0 SNP 
Array technology (>900,000 SNPs) at Capital Bio Corporation (Beijing, China).  We 
used default parameters for the Birdseed algorithm (version 2) to determine genotypes for 
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all samples (Affymetrix, Santa Clara, CA, USA).  Genotypic data were analyzed using 
the Affymetrix Genotyping Console 3.1 (Affymetrix) and included all autosomes but 
excluded the X and Y chromosomes and mitochondrial genome.  
 
Principal components analysis 
We performed principal components analysis (Fig. 2.1) based on genetic distances 
as previously described (Xing et al., 2009). This analysis indicates that Tibetans form a 
distinct group but are genetically similar to the combined CHB-JPT population (CHB = 
Chinese in Beijing, China; JPT = Japanese in Tokyo, Japan), which serves as an 
appropriate lowland East Asian comparison population (panel A of Fig. 2.1). The CEU 
(U.S. Utah residents with ancestry from northern and western Europe) and YRI (YRI = 
Yoruba in Ibadan, Nigeria) HapMap populations provide context for the patterns of 
variation observed among these populations (The International HapMap, 2005).  
 
Estimates of relatedness 
We collected samples at a small town health center where groups of semi-
nomadic clans visit. Prior to genotyping, we excluded first-degree relatives who visited 
the clinic.  It is possible that related individuals were examined at different times 
throughout the collection process; therefore, relatedness could only be determined after 
genotype analysis.  We used pair-wise genetic distances and the proportion of shared 
genomic segments to determine relatedness between subjects (Gusev et al., 2009; Xing et 
al., 2009).  When pairs of individuals exhibited genetic distances less than 4.95 x 10
-2
 or 
had genomewide identity-by-descent of greater than 400cM (minimum segment size  
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Figure 2.1: Principal Components Analysis (PCA) of Tibetans and the HapMap 
populations based on genome-wide SNP data. CHB = Chinese in Beijing, China; JPT = 
Japanese in Tokyo, Japan; YRI = Yoruba in Ibadan, Nigeria; CEU (U.S. Utah residents 
with ancestry from northern and western Europe) (10). (A) PCA of Tibetans and East 
Asian populations (CHB and JPT).  (B) PCA of Tibetans and HapMap populations. The 
Tibetans are genetically most similar to (but still distinct from) the CHB-JPT populations; 
therefore, the CHB-JPT population comparison for XP-EHH analysis is appropriate for 
identifying regions of the genome subject to positive selection in Tibetans.  
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2.5cM), one member of the pair was excluded from the analyses. Based on these criteria, 
a total of 31 unrelated individuals were included in the analyses.  
 
A priori functional candidate list  
 We generated a list of genes likely related to high-altitude adaptation based on 
categories provided in Table 2.1.  We coupled genes associated with Gene Ontology 
(GO) categories (Gene Ontology, 2006) that may be involved in the observed high-
altitude Tibetan phenotypes (481 genes), with genes listed in the “Hypoxia response via 
HIF activation” defined by Panther Pathways (33 genes) (Mi et al., 2007).  Potential 
candidate genes identified in the mitochondrial genome and on the X chromosome were 
not considered for this study.  
Although the intersection of functional and selection candidate lists is enriched for 
hypoxia-related signals of selection, the ten genes we identified probably do not account 
for all high-altitude adaptive traits in this population. For example, the genomic region 
containing HIF1AN, an inhibitor of HIF in normoxic conditions, was significant in both 
the XP-EHH and iHS tests, although it was not included in our a priori list of functional 
candidates (Fig. 2.2; Table 2.2).  Other genes in our functional candidate list are found 
within regions identified in the top 2% of the selection scans, such as the human ß-globin 
gene cluster (Table 2.2).  These post hoc findings reflect the conservative approach used 
to define our list of genes for high-altitude adaptation in Tibetans.  
 
Admixture analysis 
 A model-based algorithm implemented in ADMIXTURE (Alexander et al., 2009) 
was used to determine the genetic ancestries of each individual in a given number of 
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Gene pathways and ontology categories used to define  
an a priori functional candidate gene list 
 
 
Source Accession N 
Gene Ontology (GO) Categories 
       Detection of oxygen GO:0003032 14 
     Nitric oxide metabolic process GO:0046209 37 
     Oxygen sensor activity GO:0019826 2 
     Oxygen binding GO:0019825 46 
     Oxygen transport GO:0015671 29 
     Oxygen transporter activity GO:0005344 14 
     Response to hypoxia GO: 0001666 141 
     Response to oxygen levels GO:0070482 157 
     Vasodilation GO:0042311 41 
Panther Pathway  
       Hypoxia response via HIF activation  P00030 33 
  
Total number of unique genes: 247 
 
 
Each ontology category and the number of respective genes are provided above.  In order 
to enrich for hypoxia-related genes within the top selection candidate regions of the 
genome, we limited our focus to these a priori functional candidate genes.  
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Figure 2.2: Selection candidates involved in the hypoxia-inducible factor (HIF) 
pathway.  Genes identified as selection candidates that are related to the HIF 
pathway (outlined in black) are illustrated below (gene descriptions and regulation 
during hypoxic/normoxic conditions are provided in Table 2.3; note that HIF1AN 
was not included on the a priori functional candidate list but was identified by 
both XP-EHH and iHS analyses; Table 2.2). Genes indicated in the grey boxes are 
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Table 2.2 
 
 Genes identified in the overlap of selection candidate and functional candidate gene lists
Gene identified in 200kb region XP-EHH score 
XP-EHH empirical  
uncorrected p-value iHS score 
iHS empirical 
uncorrected p-value 
EPAS1  0.82 0.002 - - 
Endothelial PAS domain protein 1  
CYP2E1  0.71 0.007 - - 
Cytochrome P450, family 2, subfamily E, 
polypeptide 1 
EDNRA 0.7 0.008 - - 
Endothelin receptor type A 
ANGPTL4  0.69 0.008 - - 
Angiopoietin-like 4 
CAMK2D  0.68 0.009 - - 
Calcium/calmodulin-dependent protein 
kinase II delta 













,   -   
Egl nine homolog 1 
HMOX2 - - 3 0.001 
Heme oxygenase (decycling) 2 
CYP17A1 - - 4 0.007 
Cytochrome P450, family 17, subfamily A, 
polypeptide 1 
PPARA - - 3.58 0.009 
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populations without using information about population designation.  To eliminate the 
effects of SNPs that are in linkage disequilibrium (LD), we first filtered out SNPs that 
had r
2 
> 0.2 within 100kb using PLINK (Purcell et al., 2007), as recommended by the 
authors of ADMIXTURE. The pruned data set contains 142,888 SNPs.  
While the demographic history of the Tibetan Plateau is unclear (i.e., whether 
modern Tibetans descended from populations who occupied this region during the mid-
Holocene, the Late Pleistocene, or if they are an admixed population (Zhao et al., 2009)), 
this analysis indicates a distinct relationship between Tibetans and East Asian (CHB-JPT) 
populations.  We see no strong evidence of admixture in our samples (Fig. 2.3), although 
signals of selection should be detectable even if Tibetans were admixed or descended 
from populations who occupied this region prior to or during the mid-Holocene.  
 
Selection analyses 
 We used the Beagle software package to estimate phase in the 31 unrelated 
Tibetan individuals (Browning and Browning, 2009) and calculated all selection statistics 
from the phased data.  To calculate iHH for each allele at each site, we integrated the 
expected EHH in both directions from the core SNP until expected EHH was less than or 
equal to 0.10 (Huff et al., 2010; Voight et al., 2006).  To calculate iHS, we calculated the 
log of the ratio of iHH scores at each site for the derived and ancestral alleles, 
standardizing within each population by the derived allele frequency.  We computed iHS 
scores in this manner for all SNPs on the Affymetrix 6.0 microarray with at least10 
copies of the derived allele and the ancestral allele in a given population.  For the iHS 
selection scan, our test statistic for each 200kb genomic region was the fraction of SNPs  
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Figure 2.3: Individual grouping inferred by ADMIXTURE at K = 4. Each individual’s 
genome is represented by a vertical bar composed of colored sections, where each section 
represents the proportion of an individual’s ancestry derived from one of the K ancestral 
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Table 2.3 
 
Description of genes identified in the overlap of selection  
candidate and functional candidate gene lists 
 
Gene Description Category 
EPAS1(HIF2A)   HIF-family transcription factor; up-regulated 
under hypoxic conditions, regulates vascular 
endothelial growth factor expression, 
erythropoietin expression in the brain and liver 
GO: Response to 
hypoxia, Response 
to hypoxia levels 
CYP2E1(CPE1)  Catalyzes many reactions involved in drug 
metabolism and synthesis of cholesterol, steroids 
and other lipids 
GO:Oxygen 
binding 
EDNRA (ET-A)  Encodes a cell surface receptor for endothelin-1 GO: Response to 
hypoxia, Response 
to hypoxia levels 
ANGPTL4(FIAF)  Directly involved in regulating glucose 
homeostasis, lipid metabolism, and insulin 
sensitivity and also acts as an apoptosis survival 
factor for vascular endothelial cells 
GO: Response to 
hypoxia, Response 
to hypoxia levels 
CAMK2D(CAMKD)  Serine/threonine protein kinase family and to the 
Ca(2+)/calmodulin-dependent protein kinase 
subfamily; mediates nitric oxide production in 
response to changes in intracellular calcium   
GO: Response to 
hypoxia, Response 
to oxygen levels 
EGLN1(PHD2)  Catalyzes post-translational hydroxylation of the 
two HIF alpha proteins (HIF1a and HIF2a), 
targeting them for proteasomal degradation in 
normoxic conditions 
Panther: Hypoxia 
response via HIF 
activation;  
GO: Response to 
hypoxia, Response 
to oxygen levels 
HMOX2 (HO-2)  Involved in oxygen sensing independent of the 
HIF pathway; enhanced expression preserves 
endothelial cell viability during hypoxia; the 
NmrA-like family domain containing 1 (NMRAL1) 
gene, which encodes a protein involved in NO 
synthesis,  is located within the region containing 
HMOX2  
GO: Response to 
hypoxia, Response 
to oxygen levels 
CYP17A1(CPT7)  Mono-oxygenases which catalyze many reactions 
involved in drug metabolism and synthesis of 
cholesterol, steroids and other lipids 
GO: Oxygen 
binding 
PPARA (NR1C1)  Nuclear hormone-binding protein transcriptional 
regulator that controls the peroxisomal beta-
oxidation pathway of fatty acids 
GO: Response to 
hypoxia, Response 
to oxygen levels 
PTEN (TEP1)  Lipid phosphatase, tumor suppressor that 
antagonizes the PI3K-AKT/PKB signaling 
pathway, thereby modulating cell cycle 
progression and cell survival. Loss of PTEN 
increases HIF activity  
Panther: Hypoxia 




(Mi et al., 2007; Gene Ontology Consortium, 2006) 
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in each region where |iHS|>2.0, excluding regions with fewer than 5 SNPs (Huff et al., 
2010; Voight et al., 2006).  We calculated XP-EHH at each site using the default settings 
of the XP-EHH software (http://hgdp.uchicago.edu/Software/).  For the XP-EHH 
selection scan, our test statistic was the maximum XP-EHH score in each 200kb region 
(Sabeti et al., 2007).   
 We determined statistical significance for each 200kb region from the empirical 
distribution of each test statistic.  Our selection candidates are those genes contained in 
any of the 200kb regions significant at the 0.01 level in either test, excluding regions 
where the iHS test was significant at the 0.01 level in neighboring populations from 
Mongolia (n = 25 ), India  (n = 25), Nepal (n = 25), China and Japan (CHB-JPT: n = 90), 
Kyrgyzstan (n = 25), and Thailand (n = 25) (unpublished data for samples provided by 
Scott Woodward and the Sorenson Molecular Genealogy Foundation, Salt Lake City, 
Utah, USA).  The goal of this exclusion step was to enrich for signals of local adaptation 
in the Tibetan population by filtering out signals of selection present in other Asian 
populations.  Our exclusion criteria only included significant iHS results because the 
comparison population (CHB-JPT) in the XP-EHH test directly controls for genomic 
variation in a neighboring population.  (Appendices A.1 and A.2 contain all 200kb 
genomic regions identified in the top 2% of each selection scan.)  
 
Analyses for localization of selection signal 
 Although the composite of multiple tests (CMS) statistic is not applicable for 
localization of our selection signals (due to a lack of detailed information about Tibetan 
demographic history), we have conducted analyses for the three additional statistics 
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reported by Grossman et al.: FST, DDAF, and DiHH (Grossman et al., 2010).  If 
demographic information were available, these statistics could be combined into a single 
test, but we present the separate results of each test for the ten gene regions described.  
 
Phenotype collection 
Hemoglobin concentration, hematocrit, and percent oxygen saturation were 
determined from venous blood samples using the Mindray Hematology Analyzer (BC-
2300, Shenzhen, People’s Republic of China) and the Pulse Oximeter (Ohmeda 3700 
Pulse Oximeter, Datex-Ohmeda, Boulder, Colorado, USA), respectively.  Hematocrit 
values are highly correlated with [Hb] (r = 0.861, p < 10
-9




For the five iHS selection candidates that intersect our functional candidate list 
(Table 2.2), we identified the putatively advantageous haplotypes as those carrying the 
SNP alleles responsible for the most extreme iHS scores within the corresponding 200 kb 
genomic region.  Ideally, we would test for a direct correlation between the advantageous 
genetic variants and Hb concentration.  However, our selection scan results provide only 
indirect inferences about SNPs that are linked to the putatively advantageous variant.  
Because the sign of an iHS score indicates an excess of homozygosity around the 
ancestral (+) or derived (-) allele, the allele designated by an extreme iHS score is 
frequently linked closely to the advantageous allele during a selective sweep.  Therefore, 
we selected the three alleles exhibiting the most extreme iHS scores within each 200kb 
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Table 2.4 
 
Phenotype and core haplotype data for 30 Maduo Tibetan individuals 
     
Number of selection candidate haplotypes per individual 
Age Gender Hemoglobin (g/dL) Hematocrit (%) Oxygen Saturation (%) EGLN1 PPARA HMOX2 CYP17A1 PTEN 
22 F 14.4 40.1 91 0 2 2 0 1 
62 F 19.4 57.5 86 1 1 1 1 2 
31 M 10.1 32.7 88 2 2 2 0 2 
56 F 13.2 38.3 89 2 1 2 1 1 
56 M 16.0 44.3 87 1 2 2 1 0 
36 F 13.8 38.4 92 2 2 2 0 1 
66 F 16.1 45.5 85 2 2 2 0 1 
45 M 17.8 69.3 86 0 2 2 1 0 
56 F 14.9 44.4 83 2 2 2 1 1 
29 M 18.7 53.2 91 0 1 2 0 0 
34 M 19.4 53.5 85 1 1 1 0 1 
32 M 22.3 64.3 90 1 1 2 0 1 
36 F 14.9 43.4 91 0 2 2 2 2 
44 M 15.9 44.9 84 2 2 2 1 1 
23 F 12.7 37.3 88 2 1 1 0 0 
60 F 14.6 41.9 84 2 1 1 1 1 
33 F 15.5 44.7 86 1 2 2 2 1 
23 F 15.6 43.4 86 1 2 1 1 2 
17 F 14.7 42.2 90 1 2 2 0 0 
62 M 15.5 42.8 87 1 2 1 0 0 
38 M 17.7 50.5 81 2 0 1 2 1 
29 M 16.4 49.4 84 2 2 1 0 1 
46 F 17.9 51.4 83 0 2 1 1 2 
44 M 16.0 45.2 86 1 2 2 0 1 
40 F 16.9 47 87 2 1 2 1 1 
36 F 16.4 47 85 1 2 1 0 0 
40 F 17.0 49 - 1 2 2 1 2 
53 F 19.5 56.6 79 2 0 2 2 0 
30 F 13.4 38.4 89 2 2 2 0 1 
27 F 12.9 38.4 85 2 2 2 1 2 
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SNPs used to define the selection candidate haplotypes for iHS genotype-phenotype analysis 
 
 
Gene in  
200kb 
region 
First Allele of Core Selection Haplotype Second Allele of Core Selection Haplotype Third Allele of Core Selected Haplotype 
HG 18 























229793717 2.68 A T 
Chr1: 
229667980 2.45 T C 
Chr1: 
229665156 2.34 T C 
CYP17A1 
Chr10: 
104568521 4.00 G C 
Chr10: 
104594906 -3.54 G T 
Chr10: 
104517420 3.49 C G 
PTEN 
Chr10: 
89770364 3.90 G C 
Chr10: 
89790851 2.72 C T 
Chr10: 
89778618 2.68 C T 
HMOX2 
Chr16: 
4456093 3.00 C T 
Chr16: 
4465266 2.87 T C 
Chr16: 
4442515 2.84 T C 
PPARA 
Chr22: 
44827140 3.58 A G 
Chr22: 
44832376 -2.72 C A 
Chr22: 
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genomic region to construct haplotypes that partially tag the putatively advantageous 
variants. We are able to test for an association between the putatively advantageous 
haplotypes at these loci and a phenotype.  Stepwise linear regression (MATLAB R2009b) 
was used to detect significant relationships between these genotypes and hemoglobin 
concentration in 30 Tibetan individuals (after excluding one tobacco smoker) (Fig. 2.4; 
Tables 2.5, 2.6, 2.7) and oxygen saturation in 29 individuals (after exclusion of one 
missing data point).  
 
Verification of linear multivariate regression  
 To check the reliability of the stepwise linear multivariate regression method that 
we used to test for an association of genotypes with [Hb], we used the genomewide SNP 
data to generate an empirical p-value distribution to compare with the theoretically 
expected distribution.   We repeated the regression analysis for the same 30 unrelated 
Tibetan individuals for each SNP, retaining the original values for the sex, male age, 
female age, and [Hb], but changing the value of the SNP genotype variable.  This value 
was replaced with the genotype (in the corresponding individuals) at each  SNP selected 
from the autosomes, subject to the constraints that (1) the SNP contained no missing data 
(no ‘No Call’ genotypes); (2) the minor allele frequency of each SNP was ≥ 15% (i.e., the 
minor allele was observed at least nine times in the 60 chromosomes).  398,020 SNPs 
meet these criteria.  The regression method tests the variable against the null hypothesis 
that the effect size coefficient for that variable would be zero if it were included in the 
regression model and reports the resulting p-values.  
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Figure 2.4: Genotype-phenotype association of the inferred adaptive EGLN1 and PPARA 
haplotypes with hemoglobin concentration. Hemoglobin concentrations are plotted 
against the number of putatively advantageous haplotypes at (A) EGLN1 and (B) PPARA 
(from 0 to 2 haplotype copies) for 30 Tibetan individuals. A box-and-whisker plot is 
overlaid on the data points to show the median (red line), upper and lower quartiles (box 
ends) and most extreme measurements (whiskers). (C) Because the effects at the two loci 
are similar in magnitude, direction, and significance, they are combined here for purposes 
of illustration. Hemoglobin concentrations are plotted against the combined number of 
EGLN1 and PPARA haplotypes carried by an individual for both loci (from 0 to 4 copies) 
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Regression analysis between selection candidate haplotypes and Hb phenotype 
 
 
Predictor variables p* Effect size Standard deviation 
Sex (0 = Male, 1 = Female) 0.44 -5.27 6.78 
Male Age (0 for Females) 0.41 0.13 0.16 
Female Age (0 for Males) 0.74 0.05 0.15 
EGLN1 0.002 -20.06 5.39 
PPARA 0.0009 -14.88 4.42 
HMOX2 0.49 -4.85 6.97 
CYP17A1 0.74 1.66 4.87 
PTEN 0.87 -0.71 4.47 
* For the regression model: F(2, 27) = 9.78, p < 0.0006. Only variables with p < 0.01 individually were 








Regression analysis between EGLN1 and PPARA selection candidate  
haplotypes combined and Hb phenotype 
 
 
Predictor variable  p* Effect size Standard deviation 
Sex 0.48 -5.27 6.78 
Male Age 0.47 0.11 0.16 
Female Age 0.59 0.08 0.14 
EGLN1+PPARA
†
 0.0002 -16.76 3.85 
HMOX2 0.41 -5.67 6.83 
CYP17A1 0.61 2.47 4.72 
PTEN 0.82 -1.01 4.43 
* For the regression model: F(1, 28)= 18.93, p < 0.0002. Only variables with p < 0.01 individually were 
included in the final model. 
†
 Total number of putatively selected EGLN1 and PPARA alleles in an individual (0 – 4). 
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Results 
 
Genes likely involved in high-altitude adaptation 
We used two intersecting criteria to identify genes potentially involved in high-
altitude adaptation: First, a priori candidates for adaptation to high-altitude hypoxia were 
chosen because of their known functions.  Second, a genome-wide scan was conducted to 
identify regions that show strong evidence of local positive selection in high-altitude 
Tibetans (Fig. 2.5).  To generate a set of a priori functional candidate loci, we 
constructed a list of Gene Ontology (GO) categories  (Gene Ontology, 2006) associated 
with the traits discussed above (Table 1). We merged genes from this list with those in 
the Panther-defined pathway, “Hypoxia response via activation of hypoxia inducible 
factor (HIF)” (Mi et al., 2007), a major transcriptional regulator of oxygen homeostasis 
(Semenza, 2009) that is likely associated with high-altitude adaptation. The resulting set 
of 247 functional candidate loci is listed in Table 2.8.  
 
Genes subject to recent positive selection 
We next identified alleles subject to strong recent positive selection (a selective 
sweep) in a sample of 31 unrelated Tibetans who were genotyped for one million single 
nucleotide polymorphisms (SNPs) using the Affymetrix Genome-Wide Human SNP 6.0 
Array.  These individuals showed no evidence of admixture with Han Chinese and 
Japanese populations (Figure 2.3).  To pinpoint loci under positive selection, we first 
used the cross-population extended haplotype homozygosity (XP-EHH) statistic (Sabeti 
et al., 2007) to make comparisons between the Tibetan highland population and the 
combined HapMap Chinese (CHB) and Japanese (JPT) lowland populations   
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Figure 2.5: Identification of gene regions responsible for adaptation to high-altitude 
hypoxia in Tibetans. (A) The strategy used to identify a list of genes related to high-
altitude adaptation to hypoxia relies on three sets of genes. The set of functional 
candidates (yellow) consists of genes associated with physiological traits related to 
hypoxia (see Table 2.1 for categories). The XP-EHH (light blue) and iHS (dark blue) 
selection candidate sets comprise genes in the top 1% of the empirical  distributions of 
XP-EHH and iHS results, respectively, excluding those with evidence of positive 
selection in neighboring populations.  The intersection of functional candidates with 
selection candidates (outlined in black) is enriched for regions containing genes that 
contribute to local adaptation to hypoxia in Tibetans. The genes in the intersection of 
functional candidates with iHS selection candidates still exhibit genetic variability in the 
population. (B to D), Comparison between Tibetan and CHB-JPT genomic regions 
identified in selection scans. The top and bottom halves of each figure represents 
chromosome regions in the Tibetan (number of chromosomes = 62) and CHB-JPT 
populations (62 randomly drawn chromosomes from 90 individuals), respectively, for the 
(B) EPAS1, (C) EGLN1, and (D) HMOX2 genes identified in XPEHH, both scans, and 
iHS, respectively. The three SNPs with the highest iHS and XP-EHH scores (indicated by 
*) were designated as the core haplotype for each genomic region. All haplotypes were 
sorted to the horizontal midline of each panel based on the length of uninterrupted 
matches to the reference sequence.  
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Table 2.8 
 
List of a priori functional candidate genes 
 
* 
Genes within regions identified in the functional candidate list at p < 0.01 level 
† 
Genes within regions identified in the functional candidate list at p < 0.02 level 
†† 
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(Pickrell et al., 2009).  The XP-EHH statistic assesses haplotype differences between two 
populations and is designed to detect alleles that have increased in frequency to the point of 
fixation or near-fixation in one of the populations (Pickrell et al., 2009; Sabeti et al., 2007).   A 
comparison with the CHB-JPT sample is appropriate because these populations have historically 
lived at low altitude and exhibit a small overall genetic distance to our Tibetan samples (Figure 
2.1).  We also identified partial selective sweeps (in which the adaptive variant is not yet near 
fixation) using the integrated haplotype score (iHS), a statistic based upon the extent of decay of 
linkage disequilibrium surrounding a variant subjected to natural selection (Voight et al., 2006).  
The XP-EHH and iHS tests both have substantial statistical power to detect natural selection 
using genomewide SNP genotypes, even when sample sizes are limited (Huff et al., 2010; 
Pickrell et al., 2009).  
 
Selection candidate genes unique to Tibetans 
Many selective events are likely to be shared among multiple populations, but we wish to 
focus only on those that are specific to high-altitude Tibetan populations.  To do this, we divided 
the genome into consecutive, nonoverlapping 200kb regions and excluded those that yielded 
significant values (p < 0.01) for the iHS test in neighboring Asian populations.  Seven of the 247 
functional candidate loci were located in these excluded regions and were therefore eliminated 
from subsequent analyses.  In our Tibetan sample, we then calculated an XP-EHH and iHS 
summary statistic (see SOM) for each genomic region, using an empirical significance level of 
0.01 to identify a set of regions that exhibit evidence of local positive selection.  
This set of regions contained ten of the 240 genes from our functional candidate list 
(Table 2.8).  Six of these genes were identified by the XP-EHH test, and five were identified by 
the iHS test (one, EGLN1, was identified by both).  EGLN1 and EPAS1 are both in the HIF 
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pathway (Pruitt et al., 2005) and show elevated FST values.  Three additional loci, EDNRA, PTEN 
and PPARA, are also associated with HIF activity (Narravula and Colgan, 2001; Zundel et al., 
2000) (Fig. 2.2).  PPARA and ANGPTL4 are in the PPAR lipid metabolism pathway, and 
CYP17A1 and CYP2E1 are cytochrome P450 genes (Pruitt et al., 2005).  The two remaining 
genes in Table 2.2 are HMOX2, involved in HIF-independent oxygen sensing (Williams et al., 
2004) and hypoxic endothelial cell survival (He et al., 2010), and CAMK2D, which mediates 
nitric oxide production in response to changes in intracellular calcium (Cai et al., 2008).  
Because the selection signals correspond to 200kb sections of the genome rather than to 
individual genes, we performed additional analyses to localize the selection signal within each of 
the ten regions (Grossman et al., 2010).  For each gene of interest, we observed multiple 
localization signals near the gene or bracketing the gene.  
These results suggest that high-altitude adaptation in Tibetans has resulted from local 
positive selection on several distinct genes.  However, even in the absence of selection, some loci 
will appear in the intersection of our functional candidate list and selection screens just by 
chance.  To test the statistical significance of the observed pattern, we carried out a 
randomization test by resampling sets of 240 loci one million times from a list of all known 
autosomal genes (Kent et al., 2002).   For each set of randomly chosen loci, we tabulated the 
number of loci that intersected the genomic regions identified by our selection scans.  On 
average, the XP-EHH and iHS intersections contained 2.7 and 1.4 genes, respectively, which is 
significantly fewer than the six (p < 0.05) and five (p< 0.01) genes actually observed.  
 
Genotype-phenotype analysis 
In contrast to the fixed or nearly fixed alleles detected by XP-EHH, the iHS test identifies 
regions affected by incomplete selective sweeps. Therefore, interindividual genetic variation 
40 
 [Type a quote from the 
document or the summary of 
an interesting point. You can 
position the text box 
anywhere in the document. 
Use the Drawing Tools tab to 
change the formatting of the 
pull quote text box.] 
should be observable at these loci, allowing us to test for their association with Hb concentration, 
which is highly heritable and has distinctively low levels in high-altitude Tibetan populations 
(Beall, 2007).  In each of the five 200kb regions identified as targets of selection by iHS, we 
defined the selected core haplotype as the one containing the three SNP alleles that exhibit the 
most extreme iHS scores (Table 2.5).   
We then used stepwise linear regression to test for relationships between Hb 
concentration and these five core haplotypes.  The five independent predictor variables are the 
numbers of putatively advantageous haplotypes (0, 1 or 2) present in each 200kb region.  Since 
sex and age affect Hb concentration in Tibetans and Han Chinese, and the age effect differs 
between males and females (Wu et al., 2005), covariates are included in the regression analysis 
to allow an independent age effect in males and females (Tables 2.4, 2.6, and 2.7).  
The putatively advantageous haplotypes of EGLN1 and PPARA both show significant 
negative correlations with Hb concentration (p < 0.002 and 0.0009, respectively; Tables 2.6 and 
2.7).  A genomewide regression analysis showed no excess of associations (398,020 SNPs with 
minor allele frequency ≥ 0.15 and no missing genotypes).  The phenotypic effects are substantial: 
each additional copy of an advantageous haplotype at either locus decreases Hb concentration by 
~1.7 g/dl on average (Fig. 2.4).  This effect is greater than the well-established sex-related 
difference in high-altitude Tibetans (~1.1g/dl) (Wu et al., 2005).  The strong and significant 
association between Hb concentration and haplotype variation at EGLN1 and PPARA provides 
evidence of a genetic contribution to a form of high-altitude adaptation that appears to be unique 
to Tibetan populations.  
A potential explanation for the relationship between EGLN1 and decreased Hb 
concentration lies in the regulation of HIF and its target genes.  EGLN1 targets two HIF 
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proteins for degradation during normoxia, decreasing the transcription of HIF-regulated targets 
such as EPO, the erythropoietin gene whose product induces red blood cell (RBC) production 
(Fig. 2.2).  Furthermore, mutations in EGLN1 prevent targeted degradation of HIF, leading to 
polycythemia (excessive RBC production) in mice and humans (Percy et al., 2006).  
 Although PPARA has not previously been considered as a candidate gene for high-
altitude adaptation, it interacts with components of the HIF pathway.  PPARA expression is 
inhibited by HIF1 during hypoxia in mice (Fig. 2) (Zundel et al., 2000), and genes targeted by 
HIF are regulated by a HIF-independent mechanism involving PPARG coactivator-1 (Arany et 
al., 2008). In addition, a PPARA agonist, the anti-diabetic agent tesaglitazar, resulted in 
decreased Hb levels during human clinical trials (Wilding, 2007).  This effect is consistent with 
the relationship between the putatively advantageous PPARA haplotype and Hb concentration 




It is plausible that the diminished Hb levels found in Tibetans offset complications 
associated with sustained high Hb levels (e.g., hyper-viscosity) seen in non-Tibetans exposed to 
high-altitude conditions (Mejia et al., 2005; Vargas, 2006).  Alternatively, decreased Hb levels 
could be a side effect of other phenotypes which are the actual targets of natural selection. 
Functional analysis of genes such as EGLN1 and PPARA, which have undergone positive 
selection and are associated with Hb levels in this Tibetan sample, will further increase our 
understanding of genetic adaptation to high-altitude environments.  In addition, we will better 
understand the human response to hypoxia, which has important implications for treating 
mountain sickness, high-altitude pulmonary and cerebral edema, and other hypoxia-related 
diseases.  
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Abstract 
Recent studies have identified genes involved in high-altitude adaptation in 
Tibetans.  Three of these genes (EPAS1, EGLN1, and PPARA) are associated with 
relatively decreased hemoglobin levels observed in Tibetans at high altitude, providing 
corroborative evidence for genetic adaptation to this extreme environment.  The 
mechanisms that afford adaptation to high-altitude hypoxia, however, remain unclear.  
Considering the strong metabolic demands imposed by hypoxia, we hypothesized that a 
shift in fuel preference to glucose oxidation and glycolysis at the expense of fatty acid 
oxidation would provide adaptation to decreased oxygen availability.  Measurements of 
serum metabolites collected from Tibetan groups living at high altitude are consistent 
with this hypothesis: an EPAS1 haplotype that exhibits a signal of positive selection is 
significantly associated with increased lactate levels, and there is a positive relationship 
between a PPARA haplotype and serum free fatty acid levels.  Although further studies 
are required to assess the molecular mechanisms underlying these patterns, these changes 
suggest that genetic adaptation to high altitude involves alteration in energy utilization 
pathways.    
 
Introduction 
Members of the hypoxia inducible factor (HIF) pathway help to orchestrate 
molecular responses during hypoxic stress through a complex series of cellular 
metabolites (Majmundar et al., 2010).  In the absence of adequate oxygen, energy 
production from oxidative metabolism may be diminished.  At the same time, if oxidative 
metabolism proceeds in hypoxia, reactive oxidative intermediates will accumulate in 
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mitochondria.  Either of these conditions can result in cell death.  Recent work on the 
whole-organism level has revealed that HIF plays a major role in regulating metabolism, 
highlighting a strong relationship between HIF and metabolic demands in humans 
(Formenti et al., 2010).     
Native high-altitude populations have persisted for hundreds of generations in an 
oxygen-deprived (hypoxic) environment.  Recent genomewide scans of positive selection 
in Tibetans have identified hypoxia-sensing and -regulated genes as candidates for high-
altitude adaptation (Beall et al., 2010; Bigham et al., 2010; Peng et al., 2011; Simonson et 
al., 2010; Wang et al., 2011; Xu et al., 2011; Yi et al., 2010a).  A few of the candidate 
regions thought to underlie Tibetans’ successful existence were previously shown to be 
associated with their hemoglobin (Hb) levels, which are lower relative to those of native 
highland groups from the Andes or visitors to high-altitude (Beall, 2007; Beall et al., 
2010; Simonson et al., 2010; Yi et al., 2010a).  Positively selected regions containing the 
EPAS1 gene, which encodes the HIF-2 subunit, were associated with Hb concentration 
in Tibetan populations examined in two separate studies (Beall et al., 2010; Yi et al., 
2010b).  Two additional genomic regions were associated with Hb concentration in a 
Qinghai Tibetan population. One contains EGLN1, which encodes the proline 
hydroxylase, PHD2, that negatively regulates HIFs’  subunits in an oxygen-dependent 
manner (Storz et al., 2010).  The second is the genomic region containing PPARA, which 
encodes the nuclear peroxisome proliferator activated receptor alpha (PPAR) that 
regulates fatty acid metabolism and is regulated by HIF (Simonson et al., 2010).  
It is unclear whether these previously identified associations reflect direct control 
of Hb level or are consequences of natural selection acting on other advantageous traits 
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(Storz et al., 2010; Tissot van Patot and Gassmann, 2011).  The hypoxia signaling system 
triggers a pleiotropic response that increases tissue oxygenation by increasing 
vascularization and oxygen carrying capacity of the blood (Formenti et al., 2010; 
Majmundar et al., 2010).  Simultaneously, HIF signaling triggers alterations in 
metabolism to decrease tissue oxygen demand (Denko, 2008; Semenza, 1999).  Oxidation 
of fatty acids yields less ATP per molecule of oxygen consumed than oxidation of 
carbohydrates, suggesting that decreased fatty acid oxidation should also be a favorable 
adaptation to hypoxia (Holden et al., 1995).  Several studies have demonstrated decreased 
reliance on fat metabolism at high altitude, both in people living habitually at high 
altitude (Holden et al., 1995) and in those not dwelling at high altitude but acclimatized 
(Brooks et al., 1991; Roberts et al., 1996).  Another metabolic change induced by 
hypoxia is a conversion from oxidative glucose metabolism to glycolysis in order to 
maintain energy production.  This occurs through up regulation of glucose uptake and 
glycolysis and down regulation of mitochondrial glucose oxidation (Kim et al., 2006; 
Papandreou et al., 2006).  
Considering their previous association with a Tibetan-specific hypoxia-related 
phenotype and that HIF pathway members and PPAR play major roles in metabolism 
(Majmundar et al., 2010; Pruitt et al., 2005), we examined relationships between these 
genes and metabolic phenotypes in another Tibetan population.  We show here that the 
EPAS1 selected haplotype previously associated with Hb concentration is also highly 
associated with changes in serum lactate.  In addition, PPARA haplotypes exhibit an 
association with serum free fatty acids in this population.   
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Materials and methods 
DNA sample collection 
 DNA was extracted from whole blood samples for individuals (non-smokers, no 
chronic diseases). This population, who speak the Kham dialect, is from the Tuo Tuo 
River area in the Qinghai-Tibetan Plateau (~4,500 m), People’s Republic of China.  
Informed consent was obtained for all participants according to guidelines approved by 
the Institutional Review Boards at the High Altitude Medical Research Institute (Xining, 
Qinghai, People’s Republic of China).  
 
SNP genotyping 
 DNA samples were genotyped using Affymetrix 6.0 SNP Array technology 
(>900,000 SNPs) at Capital Bio Corporation (Beijing, China). We used default 
parameters for the Birdseed algorithm (version 2) to determine genotypes for all samples 
(Affymetrix, Santa Clara, CA, USA).  Genotypic data were analyzed using the 
Affymetrix Genotyping Console 3.1 (Affymetrix).  
 
Estimates of relatedness 
 We used unrelated samples as described in Simonson et al. (Simonson et al., 
2010) and the program ERSA (Huff et al., 2011) to exclude related individuals in the 
second set of Tibetan samples, excluding one member of the pair if their relationship 
exceeded that expected for first cousins. Based on these criteria, a total of 36 unrelated 
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Selection analyses 
 We performed selection scans using the iHS (Voight et al. 2006) and XP-EHH 
(Sabeti et al. 2007) test statistics, and we used iHS scores to define selected haplotypes in 
the second population as previously described (Simonson et al., 2010).   
 
Phenotype collection 
 We measured metabolites in a cohort of Tibetans, excluding related individuals 
(N=36) using kit protocols for lactate (Point Scientific, Inc., Lincoln Park, MI), -
hydroxybutyrate (WAKO Diagnostics, Richmond, VA), free fatty acids (Half Micro Test, 
Roche, Penzberg Germany) and triglycerides (Sigma Chemical, St Louis, MI).  
 
Genotype-phenotype association 
We determined whether the selection candidate regions that were previously associated 
with [Hb] (Table 3.1) are also associated with metabolites.  We defined three-SNP 
haplotypes as previously described (Simonson et al., 2010):  SNPs within 200 kb 
genomic region with the most extreme iHS scores comprise each of the putatively 
advantageous haplotypes (Hg build haplotype-defining SNPs: chromosome 1 positions 
229601735, 229604075, and 229793717 for EGLN1; chromosome 2 positions 46490868, 
46590298, and 46592661 for EPAS1; chromosome 22 positions 44807657, 44827140, 
and 44866192 for PPARA). We tested for an association between these haplotypes and 
free fatty acids, triglycerides, and 3-hydroxybutyrate in 36 Tibetan individuals.  ).  
 
Selection analyses 
We performed selection scans using the his (Voight et al.,, 2006) and XP-EHH   




Haplotype-phenotype significance values for Spearman rank-order  
correlation analysis of metabolites measured in Tibetans 
 
 EGLN1 EPAS1 PPARA 
  P value Rho  P value Rho  P value Rho 
Triglycerides 0.150 0.245 0.307 0.175 0.973 -0.006 
Free fatty acids 0.505 -0.115 0.860 -0.031 0.014 0.406 
Three hydroxybutyrate 0.230 -0.205 0.590 0.093 0.182 0.227 
Lactate 0.070 0.305 0.003 0.482 0.424 0.137 
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(Sabeti et al., 2007) statistics) used in our previous study of Tibetan high-altitude 
adaptation (Simonson et al., 2010) to identify common targets of natural selection in a 
second and distinct Tibetan population.  Both EPAS1 and EGLN1 gene regions exhibit 
significant signals of selection for the iHS test (Voight et al., 2006) (p < 0.004 and p < 
0.01, respectively), although the genomic region containing PPARA does not reach 
significance (p < 0.14) for tests of selection performed. 
 In order to determine whether these regions were also associated with variation in 
metabolites, we measured serum levels of triglycerides, free fatty acids, -
hydroxybutyrate, and lactate in non-fasted serum samples from 36 individuals.  We 
performed Spearman rank-order correlation analysis between the serum levels and the 
selected haplotypes (0, 1, or 2 copies; see Table 3.1).  Lactate was positively associated 
with the adaptive EPAS1 haplotype (p<0.003; Fig. 3.1, Table 3.1).  Additionally, the 
previously identified PPARA haplotype exhibits a positive relationship with serum free 
fatty acids (p < 0.01; Figure 3.1, Table 3.1).  The EGLN1 gene region was not associated 
with any of the serum metabolite levels measured.   
 
Discussion 
Both EPAS1 and PPARA are involved in hypoxia signaling (Aragones et al., 
2008).  Humans acutely exposed to hypoxia consequently exhibit increased anaerobic 
glucose metabolism (Kelly et al., 2010).  We observed that the adaptive EPAS1 
haplotypes were associated with increased lactate levels, consistent with decreased  






















Figure 3.1. Association of previously identified adaptive haplotypes and metabolites.  A)  
Lactate levels are plotted against the group of putatively advantageous haplotypes (0, 1, 
or 2) at the EPAS1 locus.  B) Serum free fatty acids (FFA) levels are plotted against the 
number of putatively advantageous PPARA haplotype copies (0 to 2). 
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glucose oxidation. HIF-2’s metabolic activity has been shown to be required for the 
shift to anaerobic metabolism that facilitates adaptation to hypoxia in skeletal muscle of 
mice (Majmundar et al., 2010). Additionally, individuals with Chuvash polycythemia, an 
autosomal recessive disorder in which HIF degradation is impaired, exhibit higher lactate 
levels during exercise than do normal individuals (Formenti et al., 2010). Mice lacking 
EPAS1, however, also exhibit lactic acidosis (Scortegagna et al., 2003), implying that the 
adaptive Tibetan polymorphism could be associated with either increased or decreased 
HIF-2 activity.  
A previous report demonstrates a high prevalence of hypertriglyceridemia in 
Tibetan highlanders (Sherpa et al., 2011).  We measured fasting triglyceride levels in a 
separate cohort of Tibetans and Han Chinese living in an urban environment near sea 
level, and confirmed this observation of  significantly higher triglycerides in Tibetans 
(298±23 compared to 139±8 mg/dl in the Han, p = 0.006; data not shown).  We therefore 
examined the relationship of the adapted haplotypes with serum free fatty acids and 
triglycerides in the high-altitude Tibetan samples.  Free fatty acids were associated with 
the PPARA haplotype, although serum triglycerides were not.  It should be pointed out, 
however, that the sera were not collected in the fasting state, and serum triglycerides vary 
acutely with fasting, feeding, and composition of the diet.   
Down regulation of several genes, including PPARA, involved in fatty acid 
oxidation has been observed in rats exposed to hypoxia (Kennedy et al., 2001).  PPARA 
encodes the nuclear receptor protein PPAR, a major regulator of fatty acid oxidation 
(Narravula and Colgan, 2001; Piguet et al., 2010).  Previous studies have shown that 
PPAR activation is associated with lower serum free fatty acids and triglycerides 
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(Barbier et al., 2002); hence the adaptive genotype is consistent wtih decreased 
expression or activity of PPAR. We did not, however, observe decreased -
hydroxybutyrate with the adaptive PPARA haplotype (Table 3.1), so there is no direct 
evidence of decreased fatty acid oxidation. Another explanation for increased lipids 
would be increased lipid synthesis.  Fat anabolic pathways are up regulated in hypoxia, 
mediated at least in part by up regulation of PPAR (Krishnan et al., 2009; Piguet et al., 
2010) and SREBP-1 (Li et al., 2006), but we have no data from these studies to 
specifically implicate either increased synthesis or decreased degradation of fatty acids to 
the observed phenotype.   
Recent studies suggest that some of the PPAR-dependent effects of hypoxia on 
fat metabolism may be mediated through HIF-2 (Aragones et al., 2008). Paradoxically, 
mice with either deletion of Epas1 or liver-specific over expression of Epas1 exhibit 
hepatic steatosis and both models show evidence of decreased fatty acid oxidation 
(Rankin et al., 2009; Scortegagna et al., 2003).  Thus, the interrelationships among the 
status of the primary hypoxia signaling pathways, their downstream metabolic effectors, 
and the final metabolic phenotype of the organism are highly complex. In addition, 
environmental factors are crucial in determining metabolic status. Thus, determining the 
specific roles of changes in EPAS1, EGLN1, and PPARA on the observed changes in 
metabolites will require further study. 
Hypoxia-induced regulation of metabolism and its alteration in adapted 
populations may carry implications for the risks of diabetes and obesity.  The selected 
haplotypes may result in a relative inability to shift between fat and glucose oxidation, 
so-called metabolic inflexibility (Storlien et al., 2004). Such inflexibility and fatty acid 
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oxidation capacities (Holland et al., 2007; Koves et al., 2008) are both implicated in the 
pathogenesis of type 2 diabetes mellitus.  Tibetan highlanders have a relatively low 
prevalence of diabetes (Matsubayashi et al., 2009), but the diet is also relatively low-
calorie (Beall et al., 2010) and high altitudes are associated with lower body weights 
among Tibetans (Sherpa et al., 2011).  As populations move to lower altitudes and 
encounter a more industrialized lifestyle and higher calorie diets, however, the metabolic 
adaptations to altitude could have health implications. For example, increasing total fat 
and calorie consumption with a metabolic profile that will not support fat oxidation could 
result in accumulation of lipid intermediates thought to play a role in diabetes 
pathogenesis (Holland et al., 2007; Koves et al., 2008). Further study of the metabolic 
implications of high altitude adaptation may allow interventions to ameliorate this risk 
and also identify potential new targets to treat obesity and diabetes. 
Our results demonstrate increased lactate and free fatty acids in Tibetans with 
selected haplotypes.  This pattern is consistent with the hypothesis that anaerobic glucose 
metabolism is increased and fatty acid oxidation may be decreased in the adapted 
Tibetans compared to Tibetans without the adapted haplotypes living at the same altitude. 
Controlled studies including more dynamic metabolic analyses and studies at different 
altitudes will be required to better understand the physiological significance of these 
patterns. 
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SHARED AND UNIQUE SIGNALS OF HIGH-ALTITUDE  
ADAPTATION AND PHENOTYPE ASSOCIATION  





Recent studies have used several different analytical methods to identify genes 
targeted by natural selection in high-altitude populations located throughout the Tibetan 
Plateau. Despite differences in analytic strategies and population samples, several 
hypoxia-related genes, including EPAS1 and EGLN1, were identified in multiple studies. 
By employing the same analytic strategies (iHS and XP-EHH statistics) used in our 
previous study of Tibetan high-altitude adaptation and through further comparison with a 
neighboring Mongolian population, we have identified common targets of natural 
selection in a second distinct Tibetan population from a different region of the Tibetan 
Plateau. Our selection analysis provides evidence for adaptation in two Tibetan 
populations at the p < 0.01 significance level for EPAS1, EGLN1, HMOX2, and 
CYP17A1 and p < 0.02 for PKLR, HFE, and HBB and HBG2, which have been identified 
in other studies.  By excluding the possibility of differences attributed to analytical 
methods and highlighting the relevance of admixture in studies of Tibetan populations, 
we suggest that sample location should be considered in replication studies of adaptation 




Native high-altitude populations have specific traits that afford survival to 
hypoxic (low oxygen) conditions.  Several regions of the genome, many which include 
hypoxia-sensing and -regulated genes, were recently identified as candidates for Tibetan 
high-altitude adaptation (Beall et al., 2010; Bigham et al., 2010; Peng et al., 2011; 
Simonson et al., 2010; Wang et al., 2011; Xu et al., 2011; Yi et al., 2010).  Two regions 
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that exhibit strong signals of positive selection contain genes involved in hypoxia sensing 
and response: the EPAS1 gene, which encodes the hypoxia inducible factor (HIF)-2 
subunit, and the EGLN1 gene, which encodes the proline hydroxylase PHD2 that 
regulates the alpha subunits of hypoxia induced factors in an oxygen-dependent manner.  
EPAS1 is associated with hemoglobin concentration ([Hb]) in Tibetan populations 
examined in two separate studies (Beall et al., 2010; Yi et al., 2010), and EGLN1 is 
associated with [Hb] in a Qinghai Tibetan population (Simonson et al., 2010).  In this 
same population, PPARA, which encodes the nuclear peroxisome proliferator activated 
receptor alpha that regulates fatty acid metabolism, is also significantly associated with 
Hb level (Simonson et al., 2010).  In addition to these phenotype-associated selection 
targets, many other genes have been reported by more than one study as strong targets of 
selection.   
Tibetans inhabit vast regions of the Qinghai-Tibetan Plateau, which spans 
approximately one million square miles.  At least three major Tibetan dialects are spoken 
among the geographically distinct groups located on the Plateau (Encyclopædia 
Britannica, 2011) and various groups appear to have distinct cultural characteristics.  
These differences suggest isolation of different Tibetan groups, although the 
demographic history of high-altitude populations is highly debated.  Archaeological 
evidence suggests that the ancestors of present-day Tibetan groups migrated to the 
Qinghai-Tibetan Plateau at various times, ranging from 25,000 to 5,000 years ago 
(Aldenderfer, 2011).  Patterns of genomewide SNP variation support single-route 
migration into this region (Wang et al., 2011), although analyses of mitochondrial DNA 
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variation suggest that different migrations, dating to pre- and post- Last Glacial 
Maximum, contributed to genetic variation observed among present-day inhabitants 
throughout the Plateau (Qin et al., 2010).  It is also possible that neighboring groups have 
mixed with various Tibetan groups, although this mixture is thought to be much less 
substantial than the prevalence of admixture among high-altitude counterparts in the 
Andes (Beall, 2007).  It is therefore plausible that nonoverlapping targets of selection 
may be attributed to genetic variation among distinct Tibetan populations.   
While no specific genetic variants have yet been identified as direct targets of 
selection, the genomic regions identified thus far likely harbor functional variants.  It is 
unknown whether the regions exhibiting a signal of selection harbor the same selected 
variant, or whether the same regions of the genome are under strong selection in the 
various different Tibetan groups.  It is also unknown whether phenotype associations may 
be affected by the genetic variation in each of the groups examined.  In order to evaluate 
whether our previously reported selection targets are identified in a different Tibetan 
group, we carried out analyses in a second distinct population from a different region of 
the Qinghai-Tibetan Plateau.  We performed genomewide selection scans and determined 
that many selected haplotypes are also found in second population, highlighting signals 
that warrant further investigation as important factors of genetic adaptation to high 
altitude in Tibet.  We also highlight differences in the prevalence of admixture among the 







Materials and methods 
 
DNA sample collection 
DNA was extracted from whole blood samples for 85 individuals (nonsmokers, 
no chronic diseases) residing in the Tuo Tuo River region in Qinghai province (~4,500 
m). Informed consent was obtained for all participants according to guidelines approved 
by the Institutional Review Boards at the High Altitude Medical Research Institute 
(Xining, Qinghai, People’s Republic of China).  
 
SNP genotyping 
Seventy individual DNA samples were genotyped using Affymetrix 6.0 SNP 
Array technology (>900,000 SNPs) at Capital Bio Corporation (Beijing, China).  We 
used default parameters for the Birdseed algorithm (version 2) to determine genotypes for 
all samples (Affymetrix, Santa Clara, CA, USA).  Genotypic data were analyzed using 
the Affymetrix Genotyping Console 3.1 (Affymetrix), excluding the X and Y 
chromosomes and mitochondrial genome.  
 
Principal components analysis 
We performed principal components analysis (Figure 4.1) based on genetic 
distances as previously described (Xing et al., 2009). This analysis indicates that the two 
Tibetans form a distinct group but are genetically similar to each other when compared in 
the context of other Asian groups such as the HapMap CHB and JPT populations (CHB = 
Chinese in Beijing, China; JPT = Japanese in Tokyo, Japan). The CEU (U.S. Utah 




Figure 4.1: Principal Components Analysis of two Tibetan groups from Maduo (pink) 
and Tuo Tuo River (dark blue), neighboring Monogolian populations Buryat (red) and 
Qinghai Mongolians (light blue), and HapMap populations JPT = Japanese (green) and 




Ibadan, Nigeria) HapMap populations provide context for the patterns of variation 
observed among these populations (HapMap Consortium, 2007).  
 
Estimates of relatedness 
We collected samples at a small town health center where groups of semi-
nomadic clans visit. We used the ERSA program to determine degrees of relationship 
between subjects and excluded one of any pair more closely related than second cousins 
(Huff et al., 2011).   
 
A priori functional candidate gene list 
We generated a list of genes likely related to high-altitude adaptation based on 
categories provided as described in Simonson et al. (2010).  Potential candidate genes 
identified in the mitochondrial genome and on the X chromosome were not considered 
for this study.  
 
Admixture analysis 
A model-based algorithm implemented in ADMIXTURE (Alexander et al., 2009) 
was used to determine the genetic ancestries of each individual in a given number of 
populations without using information about population designation. To eliminate the 
effects of SNPs that are in linkage disequilibrium (LD), we first filtered out SNPs that 
had r
2 
> 0.2 within 100kb using PLINK (Purcell et al., 2007), as recommended by the 





Selection scan analysis 
We performed XP-EHH and iHS tests of selection on phased data estimated by 
the Beagle software package (Browning and Browning, 2009) as previously described 
(Simonson et al., 2010).  Rather than focus on the selection candidate genes contained 
within 200kb regions significant at the 0.01 level in either test, we expanded our analysis 
to regions identified at the p < 0.02 level.  We further excluded regions where the iHS 
test was significant at this level in neighboring populations as in (Simonson et al., 2010).  
 
Genotype-phenotype association 
We identified the putatively advantageous haplotypes as previously described 
(Simonson et al., 2010) and tested whether the three alleles exhibiting the most extreme 
iHS scores within each 200kb genomic region were associated with Hb in each 
population and both populations combined.  Stepwise linear regression (MATLAB 
R2010a) was used to detect significant relationships between these genotypes and 




Patterns of selection in two Tibetan groups 
For a direct comparison of selection signals, we employed the same analytic 
strategies (iHS and XP-EHH statistics) used in our previous study of Tibetan high-
altitude adaptation to identify common targets of natural selection in a second 
linguistically distinct Tibetan population from a different region of the Tibetan Plateau 
(Simonson et al., 2010).   The first population described in Simonson et al. (2010) is a 
group of Qinghai-Tibetans who speak the Amdo Tibetan dialect (one of three major 
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Tibetan dialects spoken on the Qinghai-Tibetan Plateau); the second population, who 
speak the Kham dialect, are from the Tuo Tuo River area (Figure 1.1).   
 
Stratification in two Tibetan populations 
We used pair-wise allele sharing distances to calculate FST.  The two Tibetan 
populations exhibit the least amount of genetic differentiation from each other (FST = 
0.006), and both are equally differentiated from the Han Chinese population (FST = 0.006) 
which has commonly been used for genetic comparisons (Table 4.1).  To determine the 
extent of population structure among Tibetans and neighboring populations, we used the 
program frappe to examine the group-specific proportion of each individual’s genome 
studied (Figure 4.2).  When these six populations are compared, it is apparent that some 
of the Qinghai-Tibetans exhibit components associated with Han Chinese, suggesting 
recent admixture with this group.  Individuals from the Tuo Tuo River population, 
examined here for the first time, do not, however, exhibit a signal of admixture.   
 
Genotype-phenotype analysis for hemoglobin level 
  In our previous study of Qinghai-Tibetans, we identified associations between 
EGLN1 and PPARA selected regions and [Hb], although EPAS1 lacked enough genetic 
variation to test for an association signal considering the limited sample size of our first 
study.  The relationship between [Hb] and the EPAS1 in the second population (Tuo Tuo 
River) is also non-significant, although there is a  trend between EPAS1 and decreased 







FST between two Tibetan populations from distinct regions of the 
Qinghai-Tibetan Plateau and Mongolian and East Asian populations 
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Figure 4.2. Admixture analysis of Tibetan groups (from Maduo and Tuo Tuo River), 
neighboring Monogolian populations (Buryat and Qinghai Mongolians), and HapMAp 
populations (JPT = Japanese; CHB = Chinese). A vertical bar is used to represent the 
proportion of ancestry derived from one of the K ancestral populations. Individuals are 
arrayed along the horizontal axis and grouped by population (JPT component: green; 
CHB component: yellow; Maduo Tibetan component: pink; Tuo Tuo River Tibetan 






EGLN1 or PPARA in the second population or when the two groups are combined, 
suggesting that the signals detected in our first study could have been detected based on 
genetic variation afforded by Han Chinese admixture in the Maduo group (Figure 4.2).   
 
Overlapping, nonprotein coding regions of the genome in both Tibetan groups 
 Our selection scan analyses provide evidence for adaptation in two Tibetan 
populations at p < 0.02 for seven gene regions previously identified in our study of 
Tibetans from Maduo (Simonson et al., 2010) or other recently published studies.  The 
list of regions identified in both Tuo Tuo River and Maduo Tibetans is provided in Table 
4.2. 
In addition to the candidate list of genes we thought would likely be involved in 
high-altitude adaptation (Simonson et al., 2010), we were also interested in determining 
whether the same regions of the genome that do not contain a priori functional candidates 
exhibited a strong signal of selection in both populations using the same analytical 
methods.  Although it is difficult to make conclusions about these signals at this time, we 
highlight the regions identified in both populations here (Table 4.2). 
Considering the lack of differentiation detected through analysis of the protein-
coding regions of Han Chinese and a Tibetan group (Yi et al., 2010), it is also possible 
that many genetic targets of selection are in non-coding, regulatory regions of the 











List of selection candidate loci  
identified in Tibetans from Tuo Tuo River 
 
 
Gene Chromosome 200 kb Bin P value Selection scan 
EGLN1 Chr1 1147 1.23E-03 XP-EHH 2009 (Han) 









1148 1.54E-04 XP-EHH 2009 (Han) 








   
9.83E-03 iHS 2009 
   
9.45E-03 iHS 2010 
EPAS1 Chr2 231 1.54E-03 XP-EHH 2009 (Han) 





232 1.03E-02 XP-EHH 2009 (Han) 








   
4.09E-03 iHS 2010 
PPARA Chr22 224 9.00E-03 iHS 2009 
CYP17A1 Chr10 522 7.09E-03 iHS 2009 
   
1.40E-02 iHS 2010 
HMOX2 Chr16 22 1.29E-03 iHS 2009 
   
7.08E-04 iHS 2010 
   
1.24E-03 XP-EHH 2010 (Han) 
PKLR Chr1 767 4.33E-03 iHS 2010 
   
2.00E-02 iHS 2009 
HFE Chr6 130 1.43E-02 
XP-EHH 2009 
(Mongolian) 








      1.37E-02 iHS 2010 
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EGLN1 are found at elevated frequency (71%) in a high-altitude population from India 
and are associated with EGLN1 expression and HAPE (Aggarwal et al., 2010).  Although 
functional data are not available at this time, these SNPs are in linkage disequilibrium 
linked with the selected haplotypes identified in both of the populations we have 
examined thus far.   
To investigate whether noncoding regions of the genome could be associated with 
high-altitude adaptation, we also report shared signals of strong selection in non-protein 
coding regions of the genome and determined whether the selection candidate  
regions we identified contain hypoxia-regulated micro RNAs (miRNAs) (Table 4.3).  Of 
the overlapping noncoding regions, one of the ten contains regions that are highly 
conserved among mammals (ENCODE Consortium).  One of the regions identified in our 
first study, within the PPARA selection candidate region, contains a hypoxia-associated 




 Each of the previous reports of high-altitude adaptation in Tibet was based on a 
range of analytical methods and different Tibetan populations located throughout the 
Qinghai-Tibetan Plateau. While many of the selection candidate genes reported by these 
various studies are the same, there are also selection targets unique to each study.  By 
excluding the possibility of differences attributed to analytical methods, we highlight 
further evidence for positive selection in each of the two populations studied here at the p 








Selection candidate regions that contain hypoxia-related micro RNAs 
 
  
Genes in region Chromosome 200kb bin P value miRNA Population 
C21orf34 chr21 84 0.05 mir125b2; 
let7c 
Maduo 
PPARA,C22orf26 chr22 224 0.009 let7a3 Maduo 
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CYP17A1 (Table 4.2).  While EPAS1 EGLN1 (Bigham et al., 2010; Peng et al., 2011; 
Simonson et al., 2010; Wang et al., 2011; Xu et al., 2011; Yi et al., 2010) and EGLN1 
have been identified in various other studies, it is interesting to note that HMOX2 was 
also reported as a selection candidate in a separate study of high-altitude adaptation in a 
sample of 50 pooled Tibetan samples collected from various regions of the Plateau (Peng 
et al., 2011).  Furthermore, PKLR, and HBB and HBG2, identified in one of the 
populations studied here at the p < 0.02 level, were also reported as top selection 
candidates in an independent assessment of protein-coding regions of Tibetan genomes 
(Yi et al., 2010). 
The EPAS1 and EGLN1 genes are HIF pathway members that are associated with 
hemoglobin levels in different Tibetan populations.  Previous studies report associations 
with CYP17A1 and hypertension in European and Asian populations (Liu et al., 2011).  
HMOX2, a heme oxygenase involved in HIF-independent hypoxia sensing, may also play 
an adaptive role with respect to hypoxia tolerance. While the other two selection 
candidates, CYP17A1 and HMOX2, are not associated with the phenotypes measured 
here, they should be considered as strong candidates for future studies of genetic 
adaptation.  Our analysis of strong selection in nonprotein coding regions of the genome 
also warrant further investigation because of the lack of functional evidence within 
coding regions of the Tibetan genome (Yi et al., 2010).   
These differences suggest that background genetic variation could influence the 
extent to which selection signals are captured (the early stages of a selection sweep 
versus those that are fixed or nearly fixed in the population, see Fig. 1.2, Table 4.1) and 
possibly influence the potential for selection events to occur in different groups.  It will 
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be necessary to fully characterize the functional variants in these regions and better 
understand population history parameters and differences in phenotypic relationships in 
order to address such issues.  Furthermore, it should be determined whether variation 
caused by admixture allows for detection of genotype-phenotype relationships observed 
in the Maduo population. 
Tibetan population differences may reflect isolation of the Tibetan groups and/or 
gene flow from neighboring populations.  These differences influence the amount of 
genetic variation available to test for association between genotype-phenotype, and may 
underlie the ability to detect associations with phenotypes.  Furthermore, the regions 
identified in many of the recent selection studies may be associated with various 
unmeasured traits and perhaps secondary to the actual phenotype that affords a selective 
advantage.   Further characterization of other physiological traits is required to determine 
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Native highland populations provide an excellent opportunity to study genetic 
differentiation and adaptation.  Tibetan, Ethiopian, and Andean populations appear to 
have developed adaptive mechanisms that ensure survival despite the decreased 
availability of oxygen due to hypobaric hypoxia (Beall, 2007a).  The long-standing 
hypothesis that genetic adaptations enhance their survival is now supported by the 
research presented here and various recent genomewide studies of selection in Tibetans.   
Many genomic regions appear to afford an advantage in this extreme 
environment, and some of these loci are associated with variation in hypoxia-related 
phenotypes.  Three genes within regions targeted by selection, EPAS1/HIF2A (Beall et 
al., 2010; Yi et al., 2010), EGLN1/PHD2, and PPARA (Simonson et al., 2010), are 
significantly associated with a Tibetan-specific decreased-hemoglobin phenotype in 
different Tibetan groups, providing corroborative evidence for their role in adaptation.  
Further evidence for functional roles of EPAS1/HIF2A and PPARA is given by 
associations with lactate and free fatty acids levels, respectively, suggesting complex 
interplay of genes linked to various physiological systems.  While many signals of 
selection and phenotypic associations are shared among Tibetan groups located 
throughout the Qinghai-Tibetan Plateau, some are not.  Furthermore, associations 
detected between selection candidate genes and phenotypes appear unique to particular 
Tibetan groups, suggesting differences among Tibetan populations located throughout the 
plateau.   
Taken together, this work provides insight into the genetic factors that underlie 




these adaptive mechanisms, however, remains largely unknown.  Efforts to characterize 
the precise variants and molecular mechanisms underlying this adaptation will have 
implications for understanding human biological processes, including hypoxia tolerance, 
which involves a variety of cardiovascular, pulmonary and metabolic functions.   
 By coupling information about regions of the genome subject to natural selection 
with phenotypic data collected from Tibetan populations, we have started to bridge the 
gap between genetic factors and phenotypic traits exhibited in high-altitude populations.  
Studies of populations that have historically lived in extreme conditions, such as 
hypobaric hypoxia at high altitude, will enhance the current understanding of adaptation 
in our species and help elucidate medically relevant mechanisms of biological 
homeostasis in humans. 
 
Summary and interpretation of results 
 
 We hypothesized that genes subject to natural selection that are specifically 
related to hypoxia sensing would be associated with phenotypes in native high-altitude 
Tibetan populations.  To test this, we performed selection scans and compared putatively 
advantageous haplotypes to phenotypic data collected in two Tibetan populations.  We 
identified many hypoxia-related genes in our selection candidate regions, and 
relationships between genotype and phenotype for two of these regions.   
 Recent genome-wide analyses, including the research presented here, provide the 
first lines of evidence in support of genetic adaptation to high altitude (Beall et al., 2010; 
Bigham et al., 2010; Peng et al., 2011; Simonson et al., 2010; Wang et al., 2011; Xu et 
al., 2011; Yi et al., 2010).  The analytical tools used for these analyses pinpoint: 1) 




2) regions of the genome that exhibit a striking signal of haplotype homozygosity which 
results from a rapid increase in the frequency of selected variant(s) and their neighboring 
polymorphisms (Figure 1.2).   
 Extreme signals of selection are apparent among regions of Tibetan genomes that 
contain key members of the HIF pathway.  Furthermore, three of these genes are 
significantly associated with decreased hemoglobin (Hb) levels in Tibetans.  Single 
nucleotide polymorphisms (SNPs) in the haplotype regions containing EGLN1/PHD2 (a 
negative regulator of HIF) and PPARA (a transcriptional target of HIF) exhibited 
relationships with lower Hb levels in our first study (Simonson et al., 2010) (Table 4.2); 
and SNPs in the EPAS1/HIF2A locus (which encodes the oxygen-regulated a subunit of 
the HIF-2 transcription factor) showed a significant relationship with Hb in two studies 
that tested for an association between this gene and Hb levels (Beall et al., 2010; Yi et al., 
2010).  These association signals provide corroborative evidence for adaptive roles of 
genes that appear to have undergone strong positive selection.  Several other genes, 
which have as of yet not been associated with phenotype, were independently identified 
in more than one study (Table 5.1; Figure 5.1), suggesting that there are shared signals of 
selection in populations located throughout the Qinghai-Tibetan Plateau (Chapter 4). 
 
Additional studies of high-altitude adaptation 
 
  Several studies of Tibetan high-altitude adaptation report selection signals for the 
EPAS1/HIF2A gene (Table 1.1).  Our first study identified EPAS1/HIF2A as a selection 
candidate gene by coupling a priori functional candidate gene information with a list of 





Table 5.1:  Selection candidate genes identified in more than one genome-wide study of 
high-altitude adaptation or associated with hemoglobin levels in different Tibetan 
populations. The list of all selection candidate genes reported thus far is not provided 
here as it is likely that many are false positives, which are inherent to genome-wide tests 
of selection.  Studies are numbered 1: (Simonson et al., 2010); 2: (Beall et al., 2010); 3: 
(Yi et al., 2010); 4: (Bigham et al., 2010); 5: (Peng et al., 2011); 6: (Xu et al., 2011); 7: 
(Peng et al., 2011)*Identified in the top two percent of Simonson et al. selection 







    
Gene region 1 2 3 4 5 6 7 
Associated with Hb 
level in Tibetans 
Target of selection in 
Tibetans and Andeans 
EPAS1/HIF2A x x x x x x x Studies 2 and 3  
EGLN1/PHD2 x  x x x x x Study 1 Study 4 
HBB, HBG2 x*  x       
HMOX2 x    x     
PKLR x*  x       





Figure 5.1: Map of sample locations for each of the seven published studies of high-
altitude adaptation in Tibet (location for Study 4 (Bigham et al. 2010) reported as Tibet).  





of linkage disequilibrium (LD) from polymorphic sites across the genome and identify 
extended haplotype blocks of homozygous single nucleotide polymorphisms (SNPs) that 
result from a rapid increase in the frequency of selected variant(s) and neighboring 
polymorphisms (Figure 1.2).  The EPAS1/HIF2A region exhibited a significant signal for 
a cross-population test for natural selection (XP-EHH (Sabeti et al., 2007)), which is 
particularly powerful for detecting selection events that have produced high-frequency 
(fixed or nearly fixed) variants, between a set of Han Chinese and Japanese individuals 
(Consortium, 2007) and Tibetan high-altitude dwellers from a small village in the  
northeastern region of the Qinghai-Tibetan Plateau (Maduo) and a second village 
approximately 1000 kilometers away in a village referred to as Tuo Tuo River (Figure 
1.3).   
 In addition to the strong selection signals identified in the research presented here 
(Chapters 2 and 4), two additional studies identified EPAS1/HIF2A as a target of 
selection and determined that variants in this gene are associated with lower Hb 
concentration in different Tibetan samples (Beall et al. 2010; Yi et al. 2010).  Beall et al. 
first compared more than 500,000 SNPs in a Yunnan Tibetan population (Figure 1.3) to 
publicly available Han Chinese SNP data (Hap Map Consortium, 2007) in a genome-
wide allele differentiation scan (GWADS) and identified outlier SNPs in the 
EPAS1/HIF2A gene (Beall et al., 2010).  These SNPs were genotyped in two additional 
Tibetan groups, and a subset of eight SNPs was highly associated with Hb concentration 
in both groups (Beall et al., 2010).  Rather than examining SNPs dispersed throughout the 
entire genome, Yi et al. performed exome sequencing to capture sequence information for 




population branch statistic (PBS) based on pairwise comparisons of allele frequencies 
between two Tibetan groups, Han Chinese, and a Danish outgroup, Yi and colleagues 
also identified a signal at the EPAS1/HIF2A locus.  The largest allele-frequency 
difference detected between Han Chinese (9%) and Tibetans (87%) in this study was an 
intronic SNP within EPAS1/HIF2A, captured on the exome-targeted array (Yi et al., 
2010).  Congruent with the Beall et al. study, Yi and colleagues examined SNPs in the 
EPAS1/HIF2A locus and identified an association between SNPs in this region and lower 
Hb concentration (Beall et al., 2010; Yi et al., 2010).  Based on further analysis of the 
exome data, Yi et al. concluded that selection at the EPAS1/HIF2A locus occurred rapidly 
in Tibetans.  The Tibetan-Han divergence time (2750 years) reported by Yi and 
colleagues (2010) is, however,  highly debated based on archaeological data collected 
from the Tibetan Plateau (Aldenderfer, 2011; Brantingham et al., 2010).  
 We did not detect an association between the EPAS1/HIF2A locus and Hb level in 
the second population we studied from Tuo Tuo River (Figure 1.3), although it is possible 
that there is not enough power to detect this signal based on the sample size.  We did, 
however, identify an association between this selection candidate gene and lactate levels 
in the Tuo Tuo River population (Chapter 3).  Further studies of this population, and 
direct comparisons with the as of yet unidentified selected variant, may be used to 
determine whether an association with the Hb phenotype exists in this population.    
 Additional cross-population studies performed by Bigham et al., Xu et al., Peng et 
al., and Wang et al. also indicate a selection signal for EPAS1/HIF2A in Tibetan 
populations, although no phenotypic data were analyzed.  Bigham et al. (2010) examined 




and performed a battery of genome-wide selection tests in both high-altitude groups.  
They determined that a genomic region containing EPAS1/HIF2A exhibited significant 
variation between Tibetans and HapMap Asians but not Andeans (Bigham et al., 2010).  
Xu and colleagues determined that several SNPs within the EPAS1/HIF2A region in 50 
Tibetans collected from five different areas in Tibet (Figure 5.1) exhibit significant 
differences compared to Han Chinese using two other genome-wide tests for selection: 
FST (Cockerham and Weir, 1984) and the cross-population statistic XP-CLR (Chen et al., 
2010), which detects selective sweeps in one of two populations based on allele 
frequency differences at multiple linked SNP loci (Xu et al., 2011).  Xu et al. also 
reprocessed and analyzed Qinghai-Tibetan SNP data from our first study (Chapter 2) 
using these statistics and identified a signal of selection at the EPAS1/HIF2A locus.  Xu 
and colleagues (2011) also identified a significant allele-frequency-based signal of 
differentiation at this locus, further supporting a strong signal of selection at 
EPAS1/HIF2A in the Qinghai-Tibetan population. 
 Peng et al. used the same statistics employed by Xu et al. (2011) and also identified 
the EPAS1/HIF2A selection candidate by comparing Han Chinese and 50 individuals 
randomly selected from seven different Tibetan populations located throughout the 
Qinghai-Tibetan Plateau (Figure 1.3).  The Peng et al. sequence analysis of the 
EPAS1/HIF2A gene showed that the frequencies of more than half of the SNPs compared 
in this region were significantly different between Han Chinese and Tibetans (Peng et al., 
2011).  Using this sequence information, Peng et al. also estimated a divergence time 
between these populations that is six-fold greater than the estimate provided by the 




allele frequencies between the Tibetan and Chinese at the EPAS1/HIF2A locus, neither 
the exome study (Yi et al., 2010) nor the EPAS1/HIF2A sequence analysis (Peng et al., 
2011) identified evidence for functional coding variants, suggesting regulatory variation 
could underlie adaptive function at this locus.   
 The most recently published Tibetan genomewide selection study (Wang et al. 
2011) provided results from ten tests of selection using genomewide SNP data collected 
from a Tibetan region located near Lhasa: three haplotype-based tests (iHS, and XP-EHH 
based on comparisons with HapMap Chinese and Japanese populations (Consortium, 
2007)) and seven FST analyses based on comparisons with HapMap and East Asian 
HGDP populations (Li et al., 2008; Peng et al., 2011).  EPAS1/HIF2A was identified 
among more than 50 selection candidate genes reported in this study and exhibited a 
significant selection signal for each of the tests performed (Peng et al., 2011).   
 Extreme patterns of genetic differentiation between Tibetans and other populations 
at the EPAS1/HIF2A locus provide strong evidence for selection in this genomic region 
(Beall, 2011; MacInnis and Rupert, 2011; Scheinfeldt and Tishkoff, 2010).  The 
identification of EPAS1/HIF2A in seven different studies suggests it is common 
throughout the Qinghai-Tibetan Plateau and amenable to detection by various genome-
wide tests of selection.   
 While the EPAS1/HIF2A statistical signal is clear, the precise genetic variant(s) and 
functional role(s) remain unknown.  Future studies will be necessary to determine how 
EPAS1/HIF2A contributes to adaptation to high altitude.  Such studies will help 




play, including regulation of erythropoietin, in the human response to hypoxia (Tissot van 
Patot and Gassmann, 2011).      
 A second selection candidate identified in both our Maduo and Tuo Tuo River 
studies (Simonson et al., 2010) and others (Bigham et al., 2010; Peng et al., 2011) is 
EGLN1/PHD2, which encodes prolyl hydroxylase 2 (PHD2), an oxygen-dependent  
modulator of HIFα subunits.  The EGLN1/PHD2 selection candidate region was 
significantly associated with differences in Hb concentration in our study of Tibetans 
from Maduo (Simonson et al., 2010) (Chapter 2), but not Tuo Tuo River Tibetans 
(Chapter 4) (Figure 1.3), and was not examined for a genotype-phenotype association 
with Hb levels in other studies.  While not all studies of Tibetan adaptation identified 
EGLN1/PHD2 as a selection candidate gene, reports of genetic adaptation in New World 
high-altitude populations suggest that an EGLN1/PHD2 haplotype, distinct from that 
identified as a selection target in Tibetans, exhibits a signature of selection in high-
altitude Andeans (Table 1.1) (Bigham et al., 2010; Bigham, 2009).   
 No functional variants have been published for EGLN1/PHD2 thus far; however, 
polymorphisms in the first intron of this gene are found at elevated frequency in a high-
altitude population in India and are associated with EGLN1/PHD2 expression levels and 
incidence of high-altitude pulmonary edema (HAPE) in this population (Aggarwal et al., 
2010).  However, our recent preliminary studies identified a high frequency variant in the 
first exon of EGLN1/PHD2 in Tibetans (Lorenzo et al. abstract submitted).  Efforts to 
characterize the genetic and functional underpinnings at the EGLN1/PHD2 locus and to 




Andean high-altitude populations will help to answer long-standing questions in the field 
of high-altitude research (Beall, 2000; Beall, 2007b; Bigham et al., 2010; Moore, 2001). 
While EGLN1/PHD2 and EPAS1/HIF2A regulate various aspects of tissue and cellular 
homeostasis, the PHD/VHL/HIF axis is directly involved in erythropoiesis (Furlow et al., 
2009; Lee, 2008).  It is unclear whether coordinated signaling mediated by these adaptive 
HIF pathway members directly or indirectly affects Hb level (Beall, 2011; Storz et al., 
2010), as the precise variants and their functions remain to be determined.  Attempts to 
understand molecular mechanisms of these genes are further complicated, as hypoxia is 
not the only regulator of HIF.  Iron, oxygen radicals, nitric oxide, heat shock proteins 
(HSP), spermidine/spermine-N-acetyltransferase-2 (SSAT2) (Semenza, 2010), in 
addition to other factors such as epigenetic modifications may also play an important role 
in HIFs’ regulation.  Furthermore, selection imposed by environmental extremes (other 
than hypoxia) at high altitude may also influence, or be influenced by, altered HIF 
pathway activity.  While a discussion of these factors is outside of the scope of the 
research presented here, they may also contribute to the complexity of HIF regulation that 
appears to be uniquely coordinated in Tibetan populations.   
 
Metabolic challenges to high-altitude hypoxia 
  In addition to selection targets directly involved in the hypoxia-sensing pathway, 
selection studies have identified genes that encode members of metabolic pathways that 
respond to HIF signaling (Semenza, 2011).  PPARA (the nuclear receptor peroxisome 
proliferator activated receptor alpha), a master regulator of fatty acid oxidation, is 
identified as a selection candidate and is associated with decreased hemoglobin levels in 




that inherited alterations in genes that regulate metabolism, such as PPARA and other 
downstream targets, may compensate for wide-ranging changes inherent to global 
alterations in the HIF pathway.   
 The most obvious adaptive metabolic change induced by hypoxia is a conversion 
from oxidative glucose metabolism to glycolysis in order to maintain energy production, 
which has been well described and shown to depend largely upon HIF signaling (Denko, 
2008; Semenza, 1999).  Certain adaptive changes, such as interrupting normal HIF-
mediated hypoxic signaling in order to limit possibly maladaptive increases in 
erythrocyte mass (Prchal, 2010), may need to be balanced by other changes (e.g., 
rescuing downstream hypoxia-mediated regulatory changes that would otherwise have 
been abrogated by any global changes in hypoxia signaling).  Alternatively, orchestrated 
changes in the hypoxia-sensing pathway may allow adaptation through various aspects of 
tissue-specific and cellular homeostasis whereby Hb level is a secondary outcome (Storz 
et al., 2010).  
 
Shared and unique selection candidate genes identified in studies  
of Tibetan adaptation 
  Additional selection targets that have not yet been associated with phenotypes 
may also be biologically relevant for Tibetan adaptation.  We report selection candidate 
genes associated with phenotypes in addition to those identified in our studies and at least 
one additional study in Table 5.1, and prioritize these genes for future investigation.  The 
genomic region containing HMOX2, a heme oxygenase, reported as a top selection 
candidate in both of our studies, was also identified by Peng et al. (2011).  Two exome 




two percent of the selection candidate list in our first study: HBB and HBG2, in the 
hemoglobin beta locus, and PKLR, which is involved in red blood cell maintenance.  It 
should be noted, however, that no physiologically associated variants have yet been 
reported among Tibetans for any of the selection candidate genes discussed here.   
 While many of the selection signals converge, there are also selection targets 
unique to each study.  Some of these differences may be attributed to genetic variation 
among Tibetan populations.  At least four major Tibetan dialects are spoken (Britannica, 
2011), suggesting long-term population isolation and/or influence from neighboring 
populations that may result in genetic differentiation among groups.  While an analysis of 
genome-wide SNP variation supports a model in which the Tibetan Plateau was 
colonized via a single migration route, it is recognized that populations located 
throughout the Tibetan Plateau are likely admixed with neighboring populations (Peng et 
al., 2011).  Recent analyses of mitochondrial DNA suggest that significant 
differentiation, dating to pre- and post- Last Glacial Maximum, can be found among 
present-day inhabitants of the Tibetan Plateau (Beall et al., 2010).  It is therefore likely 
that populations located throughout this vast region have experienced different population 
histories and various degrees admixture of different neighboring populations (Zhao et al. 
2009; Qin et al., 2010; Wang et al., 2011; Aldenderfer, 2011).  Such differences could 
account for the ability to detect selection signals in some groups but not others (Wills 
2011).   
Differences in analytical methods, and their power to identify specific signals 
(Holsinger and Weir, 2009; Sabeti et al., 2007), could also help to account for some of 




frequencies are useful for identifying major single-site differences between populations, 
in contrast to within-population, haplotype-based sweeps that may be present and 
strongly detectable at intermediate allele frequencies (Huff et al., 2010; Voight et al., 
2006).  One example is the PPARAhaplotype, which exhibits a significant iHS signal 
and is correlated with hemoglobin concentration in the Qinghai-Tibetan population 
(Simonson et al., 2010) but has not been reported as a selection candidate in other studies.  
It is possible that natural selection on PPARAis either unique to the Qinghai-Tibetan 
population or has not been identified in other populations due to methodological 
differences. 
Peng and colleagues (2011) genotyped three EPAS1/HIF2 outlier SNPs identified 
in their Tibetan samples and three haplotype SNPs reported by Simonson et al. (2010) for 
EGLN1/PHD2 and PPARA in more than 1334 individuals from seven Tibetan groups, 
and conclude that three, one, and none of the respective SNPs exhibit highly 
differentiated allele frequencies between Tibetans and Han Chinese and Japanese 
populations (Peng et al., 2011).  These results should, however, be interpreted with 
caution.  Positive selection may not always result in extreme allele frequency differences 
(Holsinger and Weir, 2009; Sabeti et al., 2007).  Haplotype tests of selection, for 
example, are based upon patterns of extended homozygosity across a genomic region 
rather than differences in allele frequency.  The within-population integrated haplotype 
score (iHS, Voight et al., 2006), which was used by Simonson et al. (2010) to determine 
EGLN1/PHD2 and PPARA haplotype SNPS, has the greatest power to identify selective 
sweeps when the selected variant is present at intermediate (20%-80%) frequency in a 




differences are, therefore, not necessarily expected to be observed among a subset of 
SNPs used to tag a region that exhibits an intermediate selective sweep signal.  While it 
remains to be seen whether signals identified in a signal study are true signals of selection 
or false positives, the Peng et al. (2011) analysis highlights important concepts about 




Identification of specific genetic variants targeted by selection
 
It is clear that evolutionary processes have favored specific hypoxia- and 
metabolism-related genetic factors in high-altitude Tibetans.  The associations between 
several of the selected candidate genes and a decreased hemoglobin phenotype provide 
supporting evidence for functional roles of genetic variants specific to high-altitude 
Tibetans.   
Although analysis of the protein-coding regions of the genome has been 
successful in identifying disease-causing mutations for a number of Mendelian conditions 
(Ng et al., 2010; Lupski et al., 2010; Ku et al., 2011), there is good evidence that many or 
most variants associated with complex traits and diseases may lie in noncoding regions 
(Hindorff 2009) that would be missed by examination of protein-coding regions alone.  
Such noncoding regulatory variants are increasingly recognized as important factors of 
adaptive evolution (Wray et al., 2007; Kudaravalli et al., 2009; Lappalainen et al., 2010).  
For example, strong positive selection for hereditary lactase persistence has been 
attributed to regulatory variants located ~10kb upstream of the LCT gene in two separate 
human populations (Tishkoff et al., 2007).  A recent study of 50 high-altitude Tibetan 




differentiated allele frequencies in Tibetans and Han Chinese: the SNP with the greatest 
allelic-frequency difference between these groups is an intronic variant in the 
EPAS1/HIF2A locus (Yi et al., 2010).  To avoid missing functional variants that may be 
located outside coding portions of the genome, it would be ideal to carry out whole-
genome sequencing for a more complete picture of potentially functional variation.  
With the advent of high-throughput sequencing technology, it is now possible to 
sequence a single genome for less than 5,000 dollars, and this price is estimated to 
rapidly decline in the next few years (Mardis, 2011).  Even with this present estimate in 
mind, it is conceivable that we one could obtain important variant information through 
careful selection of only a few samples, chosen to maximize the information obtained 
from many putatively advantageous regions.  Using haplotype information gathered from 
the chip analysis, samples that in combination provide the most information about 
selected and nonselected haplotypes could be selected for sequence analysis.  The regions 
of greatest interest that should be prioritized for this selection process include those 
identified in more than one of our studies (Table 5.1).   
Further consideration will be given to potential regulatory variants that may be 
involved in adaptive evolution.  To filter these targets for functional significance, the 
variants identified in sequence analysis will be compared with a subset of microRNAs 
(miRNA) that have been shown to be associated with hypoxia response (Kulshreshtha et 
al., 2008).  The entire putatively advantageous haplotype should be compared with 
specific nongenic ENCyclopedia of DNA Elements (ENCODE) regions that have been 
well-characterized in human cell lines and are highly conserved across species or exhibit 




will provide a list of potentially functional noncoding variants important for high-altitude 
adaptation.   
Sequence data will also provide valuable insight into the population history of 
Tibetans and may be used to define a parameter set that is required to perform selection 
scans on whole-genome sequence data.  The CMS test (Grossman et al., 2010) is a newly 
developed statistical method designed specifically to identify genetic variants that have 
been targeted by recent positive selection.  CMS relies on a well-calibrated model of 
demographic history to incorporate information from five or more individual tests of 
selection in a composite likelihood framework.  Previous results predict that the CMS test 
will reduce our search space from approximately 1,000 to approximately 100 candidate 
variants in each region and, in half of the cases, the true causal variant is found among 
the top 10 candidate variants (Grossman et al., 2010), providing valuable prioritization 
information within each candidate list.   
Once a handful of highly informative genomes or a sample size conducive to 
demographic analysis and subsequent genomewide selection scans is obtained, it will be 
possible to identify which coding and noncoding variant(s) are harbored within regions 
exhibiting a strong signal of positive selection in Tibetans.  This information is crucial for 




Teasing apart mechanisms of high-altitude adaptation Tibetans
 
While the work presented here and others’ studies provide a step forward in the 
field of high-altitude research, these data raise many questions regarding the mechanisms 




necessary to integrate these recent genetic advances with current knowledge of relevant 
molecular pathways and the many physiological insights afforded by decades of high-
altitude research.  Once the precise genetic variants are identified, functional analysis will 
be necessary to elucidate the precise mechanisms underlying hypoxia tolerance.   
Our analyses indicate that PPARA is also associated with increased triglyceride 
levels and may be related to shifts in energy fuel choice (fatty acid to carbohydrate 
oxidation) in order to compensate for decreased oxygen availability (Holden et al., 1995; 
McClelland et al., 1998; Roberts et al., 1996).  Misregulation of a key HIF pathway 
member has recently been shown to influence metabolic phenotypes (blood lactate levels, 
phosphocreatine levels, and acidosis in muscle) and exercise capability (Formenti et al., 
2010), suggesting a strong connection between hypoxia sensing and metabolism, 
although further research will be necessary to directly test these relationships. 
While our study and others’ studies have focused specifically on hemoglobin (Hb) 
levels, which are uniquely lower among Tibetans compared to other populations at high 
altitude, the biological mechanisms underlying this characteristic are unknown.  It is 
unclear whether this trait is directly targeted by selection and is itself advantageous or, 
alternatively, whether it is a side effect of a different adaptive trait.  An obvious 
physiological change that may provide an advantage in a low-oxygen environment is 
efficiency at some point of the oxygen transport pathway.  Characterizing each step of the 
oxygen-transport system of Tibetans located in their native high-altitude environment 
will provide insight to both genetic associations and relationships among various 
physiological traits.  By combining our genotype and additional phenotype data, we hope 




adaptation.  Future efforts will be focused on investigating whether adaptation is a 
function of hemoglobin through examination of the oxygen transport pathway in these 
individuals and determine, for the first time, the precise genetic factors underlying some 
of the other traits unique to the Tibetan population.  Thorough, complementary 
examinations of Tibetan genetics and physiology will provide unprecedented insight into 
mechanisms of high-altitude adaptation and have significant implications for 
understanding the human response to hypoxia tolerance and stress.   
 
Maladaptive responses to hypoxia
 
Future studies will also help to elucidate whether some variants within these 
genes contribute to maladaptive responses that result from limited oxygen supply.  It has 
long been observed that red blood cell production increases in response to reduced 
atmospheric oxygen pressure (Bert, 1878; Viault, 1890), and many visitors to high 
altitude develop polycythemia and concomitantly elevated hemoglobin (Hb) levels. This 
response causes higher blood viscosity and is associated with pulmonary hypertension, 
increased risk of stroke, high-altitude pulmonary edema (HAPE), and chronic mountain 
sickness, and it may influence in utero development (Beall et al., 2007; Moore, 2001).  
These consequences extend beyond altitude sickness and are relevant to clinical 
pathologies such as pulmonary hypertension, heart disease, stroke, tumor hypoxia, and 
metabolic disorders (Majmundar et al., 2010).  Further studies of high-altitude adaptation 
may allow interventions to reduce common, hypoxia-induced maladies suffered by 






Insight into recent human evolution
 
In addition to physiological and molecular aspects of high-altitude adaptation, 
genetic studies of native high-altitude populations will provide valuable insights into 
evolutionary processes.  It remains to be seen how natural selection has orchestrated 
human biological changes and how much of this fine-tuning is based upon novel or 
standing genetic variation.  It will also be important to determine if and how the selection 
candidates, some of which have been reported in more than one study (Table 5.1), are 
involved in high-altitude adaptation and whether differences reported in selection and 
association signals reflect variation in Tibetan population histories. 
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REGIONS OF THE GENOME THAT EXHIBIT STRONG SIGNALS OF 
 







200kb genomic regions identified in the top two percent of the XP-EHH selection scan 
 
Genes in XP-EHH regions Chromosome 
200kb 
Region XP-EHH value P value 
PRDM2 Chr1 70 0.60 0.0196 
PAX7 Chr1 94 0.65 0.0132 
CLIC4,RUNX3 Chr1 125 0.65 0.0127 
No genes in this region Chr1 153 0.63 0.0163 
DAB1 Chr1 288 0.69 0.0082 
No genes in this region Chr1 403 0.66 0.0114 
OR10J5,OR10J1 Chr1 788 0.69 0.0082 
No genes in this region Chr1 1060 0.80 0.0023 
USH2A Chr1 1070 0.65 0.0131 
CNIH3 Chr1 1114 0.64 0.0146 
No genes in this region Chr1 1117 0.69 0.0084 
ITPKB,C1orf95 Chr1 1124 0.72 0.0064 
TRIM67,C1orf124,GNPAT,C1orf131, 
EGLN1, 
EXOC8 Chr1 1147 0.86 0.0012 
TSNAX,EGLN1 Chr1 1148 0.96 0.0002 
DISC1 Chr1 1149 0.92 0.0002 
AKT3 Chr1 1210 0.65 0.0134 
KLF6 Chr10 19 0.79 0.0028 
DHTKD1,NUDT5,SEC61A2,CDC123 Chr10 61 0.61 0.0185 
SEPHS1,BEND7 Chr10 67 0.74 0.0054 
RSU1,CUBN Chr10 84 0.65 0.0125 
No genes in this region Chr10 147 0.66 0.0110 
MBL2 Chr10 271 0.60 0.0198 
No genes in this region Chr10 272 0.76 0.0039 
No genes in this region Chr10 273 0.69 0.0086 
ANK3 Chr10 308 0.73 0.0055 
LRRC20,NPFFR1,PPA1,SAR1A Chr10 358 0.64 0.0149 
CDH23,C10orf54 Chr10 365 0.61 0.0183 
RPS24,POLR3A Chr10 397 0.64 0.0148 
CHUK,ERLIN1,CWF19L1,SNORA12,CPN1 Chr10 509 0.86 0.0011 
BLOC1S2,SCD,PKD2L1,CWF19L1 Chr10 510 0.89 0.0007 
WNT8B,HIF1AN,SEC31B,NDUFB8 Chr10 511 0.81 0.0017 
PAX2 Chr10 512 0.60 0.0199 
NCRNA00081,PDCD4,SHOC2 Chr10 563 0.78 0.0035 
No genes in this region Chr10 609 0.62 0.0170 
ADAM12 Chr10 639 0.62 0.0169 
FRG2B,SYCE1,DUX4,CYP2E1,LOC728410,
LOC653544,LOC653545,LOC653543 Chr10 676 0.71 0.0074 
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Genes in XP-EHH regions Chromosome 
200kb 
Region XP-EHH value P value 
HBD,OR51B2,OR51B5,HBG2,HBBP1, 
OR51M1,HBE1,HBG1,HBB,OR51B6, 
OR51B4 Chr11 26 0.63 0.0158 
TRIM34,UBQLNL,TRIM6-
TRIM34,OR52H1,OR52B6,TRIM6,OR52D1, 
UBQLN3,OR51I1,OR51Q1,OR51I2 Chr11 27 0.64 0.0150 
TEAD1,RASSF10 Chr11 64 0.62 0.0169 
No genes in this region Chr11 65 0.66 0.0109 
TMEM86A,SPTY2D1,PTPN5,IGSF22 Chr11 93 0.66 0.0109 
PRMT3,SLC6A5 Chr11 102 0.84 0.0013 
NELL1,SLC6A5 Chr11 103 0.67 0.0100 
LUZP2 Chr11 124 0.71 0.0075 
ALX4,EXT2 Chr11 221 0.62 0.0178 
APLNR,LRRC55 Chr11 283 0.66 0.0112 
KCNE3,POLD3 Chr11 369 0.74 0.0052 
RNF169,CHRDL2,POLD3 Chr11 370 0.61 0.0189 
C11orf87 Chr11 544 0.67 0.0102 
SC5DL Chr11 603 0.79 0.0032 
BLID,LOC399959 Chr11 607 0.76 0.0042 
OPCML Chr11 659 0.62 0.0174 
CCDC77,SLC6A13,JARID1A Chr12 1 0.74 0.0052 
CCDC77,NINJ2,B4GALNT3 Chr12 2 0.64 0.0140 
CACNA1C Chr12 10 0.73 0.0060 
CACNA1C Chr12 11 0.66 0.0119 
BCL2L14,LOH12CR2,LRP6,MANSC1 Chr12 61 0.66 0.0118 
No genes in this region Chr12 143 0.67 0.0101 
SYT10 Chr12 167 0.82 0.0015 
OR10AD1,PFKM,C12orf68,ASB8 Chr12 234 0.73 0.0058 
DYRK2 Chr12 331 0.80 0.0025 
FGD6,VEZT Chr12 470 0.69 0.0079 
NUAK1 Chr12 524 0.62 0.0179 
No genes in this region Chr12 562 0.65 0.0136 
No genes in this region Chr12 587 0.67 0.0105 
CCDC64 Chr12 594 0.75 0.0048 
TMEM120B,LOC338799,HPD,SETD1B, 
RHOF Chr12 603 0.63 0.0156 
PSMD9,WDR66,BCL7A Chr12 604 0.72 0.0063 
No genes in this region Chr12 631 0.62 0.0179 
No genes in this region Chr13 429 0.61 0.0181 
NALCN,ITGBL1 Chr13 504 0.61 0.0195 
ING1,CARKD,RAB20,CARS2 Chr13 550 0.78 0.0034 
ANKRD10 Chr13 551 0.63 0.0165 
MAX Chr14 323 0.61 0.0194 
RAD51L1 Chr14 340 0.68 0.0089 
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Genes in XP-EHH regions Chromosome 
200kb 
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WDR21A,DPF3,RBM25,ZFYVE1 Chr14 362 0.62 0.0180 
TMEM63C,KIAA1737,ZDHHC22 Chr14 383 0.66 0.0120 
TTC8 Chr14 442 0.63 0.0157 
FSIP1,THBS1 Chr15 188 0.64 0.0138 
No genes in this region Chr15 219 0.75 0.0044 
KIAA0256,SHC4 Chr15 235 0.63 0.0159 
WDR72 Chr15 257 0.62 0.0171 
RFX7 Chr15 271 0.77 0.0036 
MCTP2 Chr15 464 0.61 0.0183 
No genes in this region Chr15 465 0.69 0.0086 
TELO2,C16orf38,UNKL,LOC283951, 




CRAMP1L Chr16 8 1.04 0.0001 
NDE1,MYH11,KIAA0430 Chr16 78 0.77 0.0035 
GSG1L Chr16 139 0.74 0.0055 
No genes in this region Chr16 266 0.74 0.0049 
No genes in this region Chr16 311 0.76 0.0039 
WWOX Chr16 385 0.69 0.0080 
CDH13 Chr16 408 0.62 0.0173 
MLYCD,HSBP1,OSGIN1,NECAB2 Chr16 412 0.65 0.0126 
MAP1LC3B,ZCCHC14,FBXO31 Chr16 429 0.65 0.0124 
DHX40P,HEATR6,CA4 Chr17 277 0.74 0.0051 
WIPI1,ARSG Chr17 319 0.66 0.0115 
ACTG1,BAHCC1,FSCN2,C17orf70,NPLOC
4 Chr17 385 0.66 0.0112 
No genes in this region Chr18 7 0.63 0.0153 
LAMA1,ARHGAP28 Chr18 34 0.67 0.0097 
No genes in this region Chr18 54 0.62 0.0173 
No genes in this region Chr18 56 0.87 0.0009 
TCF4 Chr18 255 0.74 0.0050 
DSEL Chr18 316 0.70 0.0076 
No genes in this region Chr18 348 0.71 0.0071 




PIP5K1C Chr19 17 0.72 0.0065 
FBN3,LASS4,CCL25 Chr19 40 0.67 0.0104 
ANGPTL4,KANK3,RPS28,MARCH2, 
NDUFA7, 
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RHOB Chr2 102 0.64 0.0139 
ALK Chr2 149 0.64 0.0147 
XDH Chr2 157 0.80 0.0024 
SRD5A2 Chr2 158 0.74 0.0049 
BIRC6 Chr2 162 0.65 0.0122 
BIRC6,TTC27 Chr2 163 0.72 0.0062 
SLC8A1 Chr2 202 0.64 0.0146 
No genes in this region Chr2 215 0.79 0.0033 
PRKCE Chr2 229 0.67 0.0096 
PRKCE,EPAS1 Chr2 231 0.82 0.0015 
ATP6V1E2,EPAS1 Chr2 232 0.67 0.0103 
C2orf61,CALM2 Chr2 236 0.70 0.0079 
FSHR Chr2 246 0.64 0.0144 
AFTPH,SERTAD2 Chr2 323 0.63 0.0162 
MCEE,PAIP2B,MPHOSPH10 Chr2 356 0.81 0.0018 
ZNF638,DYSF Chr2 357 0.81 0.0018 
LOC150568 Chr2 522 0.72 0.0066 
No genes in this region Chr2 646 0.63 0.0154 
No genes in this region Chr2 686 0.61 0.0184 
GTDC1,ZEB2 Chr2 724 0.65 0.0133 
ARL5A,NEB Chr2 761 0.68 0.0096 
CACNB4 Chr2 762 0.72 0.0067 
XIRP2 Chr2 837 0.67 0.0098 
XIRP2 Chr2 838 0.68 0.0087 
DNAJC10 Chr2 916 0.80 0.0022 
CYP20A1,ABI2 Chr2 1019 0.65 0.0130 
PARD3B Chr2 1028 0.61 0.0191 
PARD3B Chr2 1029 0.80 0.0022 
LOC643905,MYEOV2,NDUFA10,OR6B3, 
OR6B2,OTOS Chr2 1203 0.66 0.0117 
No genes in this region Chr20 21 0.63 0.0163 
PLCB4 Chr20 46 0.73 0.0061 
B4GALT5,PTGIS Chr20 238 0.79 0.0029 
SPATA2,SLC9A8,RNF114 Chr20 239 0.72 0.0068 
TMEM189,TMEM189-
UBE2V1,SNAI1,UBE2V1,RNF114 Chr20 240 0.67 0.0099 
ERG Chr21 193 0.79 0.0029 
DGCR11,TSSK2,CLTCL1,DGCR2,SLC25A1, 
DGCR14,GSC2 Chr22 87 0.63 0.0159 
CLTCL1,HIRA Chr22 88 0.79 0.0031 
KIAA1644 Chr22 215 0.73 0.0056 
CELSR1 Chr22 226 0.92 0.0003 
EDEM1 Chr3 26 0.67 0.0108 
No genes in this region Chr3 29 0.70 0.0077 
No genes in this region Chr3 31 0.61 0.0187 
SRGAP3 Chr3 45 0.67 0.0106 
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THUMPD3,SRGAP3 Chr3 46 0.68 0.0095 
SETD5,THUMPD3,LHFPL4 Chr3 47 0.64 0.0152 
VGLL4 Chr3 58 0.81 0.0019 
SATB1 Chr3 92 0.88 0.0008 
No genes in this region Chr3 93 0.92 0.0004 
CADPS Chr3 313 0.64 0.0141 
ADAMTS9 Chr3 323 0.68 0.0093 
RYBP Chr3 362 0.63 0.0156 
KIAA1407,QTRTD1,DRD3 Chr3 576 0.68 0.0088 
ADPRH,TMEM39A,KTELC1,C3orf1,CD80, 
PLA1A,CDGAP Chr3 603 0.76 0.0038 
H1FOO,IFT122,RHO,RPL32P3,PLXND1, 
C3orf25,MBD4 Chr3 653 0.62 0.0166 
TRIM42 Chr3 709 0.64 0.0149 
No genes in this region Chr3 726 0.64 0.0143 
VEPH1,PTX3,C3orf55 Chr3 793 0.67 0.0107 
DGKG,ETV5 Chr3 936 0.80 0.0021 
RTP1,RPL39L,ST6GAL1 Chr3 941 0.65 0.0126 
No genes in this region Chr4 150 0.88 0.0008 
PCDH7 Chr4 152 0.64 0.0137 
No genes in this region Chr4 158 0.61 0.0182 
TBC1D1 Chr4 189 0.67 0.0099 
SLC4A4 Chr4 362 0.64 0.0145 
DMP1,MEPE,IBSP Chr4 444 0.71 0.0069 
UNC5C,BMPR1B Chr4 481 0.66 0.0111 
CENPE,BDH2,NHEDC2 Chr4 521 0.79 0.0030 
No genes in this region Chr4 522 0.62 0.0166 
No genes in this region Chr4 559 0.64 0.0153 
CAMK2D,ANK2 Chr4 572 0.68 0.0092 
TMEM155,CCNA2,EXOSC9,ANXA5, 
LOC100192379,BBS7 Chr4 614 0.76 0.0040 
TRPC3,BBS7 Chr4 615 0.79 0.0027 
No genes in this region Chr4 637 0.68 0.0091 
No genes in this region Chr4 742 0.68 0.0089 
EDNRA,TMEM184C,LOC90826 Chr4 743 0.70 0.0078 
No genes in this region Chr4 817 0.62 0.0175 
C4orf43,MARCH1,TKTL2 Chr4 823 0.62 0.0172 
No genes in this region Chr4 825 0.62 0.0177 
No genes in this region Chr5 16 0.83 0.0014 
No genes in this region Chr5 23 0.61 0.0193 
No genes in this region Chr5 95 0.64 0.0136 
RNASEN,C5orf22 Chr5 157 0.65 0.0129 
THBS4,SERINC5 Chr5 397 0.71 0.0072 
MCC Chr5 562 0.63 0.0164 
IL12B,UBLCP1 Chr5 793 0.66 0.0116 
No genes in this region Chr5 823 0.71 0.0070 
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JARID2 Chr6 77 0.64 0.0139 
HLA-DRB6,HLA-DQA1,HLA-DRB1, 
HLA-DRB5,HLA-DQB1 Chr6 163 0.65 0.0123 
IL17A,PKHD1 Chr6 260 0.64 0.0142 
PRIM2 Chr6 286 0.61 0.0189 
PRIM2 Chr6 287 0.81 0.0020 
B3GAT2,SMAP1 Chr6 358 0.75 0.0045 
No genes in this region Chr6 434 0.63 0.0161 
No genes in this region Chr6 493 0.68 0.0092 
No genes in this region Chr6 494 0.69 0.0081 
SOBP,SCML4 Chr6 540 0.61 0.0186 
NKAIN2 Chr6 624 0.86 0.0012 
AKAP7,EPB41L2 Chr6 657 0.75 0.0045 
No genes in this region Chr6 707 0.69 0.0085 
No genes in this region Chr6 708 0.63 0.0160 
UTRN Chr6 724 0.65 0.0132 
UTRN Chr6 725 0.90 0.0005 
SAMD5 Chr6 739 0.62 0.0168 
ULBP3,PPP1R14C Chr6 752 0.65 0.0135 
NOX3 Chr6 779 0.65 0.0129 
MAD1L1 Chr7 9 0.64 0.0143 
CYTH3,EIF2AK1,USP42,PMS2,JTV1 Chr7 30 0.61 0.0188 
MACC1,ITGB8 Chr7 101 0.76 0.0042 
ITGB8 Chr7 102 0.67 0.0106 
BBS9 Chr7 167 0.60 0.0197 
No genes in this region Chr7 172 0.65 0.0128 
HERPUD2 Chr7 178 0.66 0.0116 
ELMO1 Chr7 186 0.71 0.0073 
EPDR1,TXNDC3,SFRP4 Chr7 189 0.72 0.0069 
ADCY1 Chr7 227 0.60 0.0200 
PCLO Chr7 411 0.82 0.0016 
PCLO Chr7 412 0.79 0.0032 
SSPO,KRBA1,ZNF862,ZNF467 Chr7 745 0.63 0.0155 
C7orf29,REPIN1,RARRES2,LRRC61, 
GIMAP8, 
ZNF775 Chr7 748 0.62 0.0167 
CSMD1 Chr8 18 0.60 0.0196 
No genes in this region Chr8 79 0.66 0.0113 
No genes in this region Chr8 104 0.62 0.0176 
INTS9,EXTL3 Chr8 143 0.71 0.0075 
INTS9,KIF13B,HMBOX1 Chr8 144 0.68 0.0090 
LOC286135 Chr8 149 0.76 0.0041 
No genes in this region Chr8 246 0.90 0.0005 
No genes in this region Chr8 247 0.86 0.0010 
EFCAB1 Chr8 248 0.76 0.0037 
No genes in this region Chr8 327 0.66 0.0121 
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MYBL1,VCPIP1,C8orf44,SGK3 Chr8 338 0.61 0.0190 
ARFGEF1,CSPP1 Chr8 341 0.75 0.0046 
ARFGEF1,CPA6 Chr8 342 0.79 0.0026 
CPA6 Chr8 344 0.73 0.0057 
No genes in this region Chr8 384 0.67 0.0102 
No genes in this region Chr8 639 0.73 0.0059 
No genes in this region Chr8 640 0.66 0.0119 
No genes in this region Chr8 646 0.61 0.0192 
No genes in this region Chr9 124 0.73 0.0059 
TMEM215,TAF1L Chr9 163 0.75 0.0047 
MAMDC2 Chr9 359 0.80 0.0025 
KLF9,SMC5,MAMDC2 Chr9 360 0.73 0.0062 
SLC28A3 Chr9 430 0.62 0.0176 
IARS,OGN,SNORA84,NOL8,CENPP Chr9 470 0.64 0.0151 
BARX1 Chr9 478 0.71 0.0072 
PTPDC1 Chr9 479 0.74 0.0053 
No genes in this region Chr9 542 0.61 0.0193 
HSDL2,KIAA1958 Chr9 571 0.66 0.0122 
ZNF618 Chr9 578 0.68 0.0094 
ASTN2,SNORA70C Chr9 594 0.72 0.0065 


















200kb genomic regions identified in the top two percent of the iHS selection scan 
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XPR1 Chr1 894 0.0135 
ATXN7L2,CYB561D1,AMIGO1,GPR61,AM
PD2,GNAI3,SYPL2,GNAT2 Chr1 549 0.0106 
No genes in this region Chr1 964 0.0159 
TCEA3,ZNF436,HNRNPR,C1orf213 Chr1 117 0.0141 
No genes in this region Chr1 959 0.0122 
CACNA1E Chr1 898 0.0095 
No genes in this region Chr1 1117 0.0135 
PTPRF,ST3GAL3,JMJD2A Chr1 219 0.0176 
DISC1 Chr1 1149 0.0142 
SGIP1,PDE4B Chr1 333 0.0097 
PFKFB2,C4BPB,C4BPA,FCAMR,YOD1, 
C1orf116 Chr1 1026 0.0115 
No genes in this region Chr1 151 0.0094 
FAM163A,TOR1AIP2,IFRG15,TOR1AIP1, 
CEP350 Chr1 890 0.0035 
TSNAX,EGLN1 Chr1 1148 0.0098 
No genes in this region Chr1 963 0.0063 
AGBL4,ELAVL4 Chr1 251 0.0083 
No genes in this region Chr1 344 0.0093 
FCER1A,DARC,CADM3,OR10J3 Chr1 787 0.0091 
GBAP,PKLR,C1orf104,SCAMP3,MTX1, 
KRTCAP2,TRIM46,GBA,HCN3,MUC1, 
FDPS,C1orf2,CLK2,THBS3,RUSC1,ASH1L Chr1 767 0.0200 
No genes in this region Chr10 295 0.0197 
No genes in this region Chr10 286 0.0187 
ATRNL1 Chr10 584 0.0009 
WNT8B,HIF1AN,SEC31B,NDUFB8 Chr10 511 0.0020 
ENTPD1,CCNJ,LOC100127889,CC2D2B Chr10 488 0.0042 
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TRIM8,CYP17A1,ARL3,SFXN2,C10orf26 Chr10 522 0.0071 
MYOF Chr10 475 0.0143 
No genes in this region Chr10 550 0.0008 
FRMPD2 Chr10 245 0.0026 
PTEN,KILLIN Chr10 448 0.0072 
CUEDC2,C10orf95,GBF1,NFKB2,PSD, 
FBXL15 Chr10 520 0.0159 
C10orf32,AS3MT,CNNM2 Chr10 523 0.0164 
PAX2 Chr10 512 0.0001 
ZNF37A,LOC100129055 Chr10 192 0.0070 
ATRNL1 Chr10 585 0.0051 
C10orf125,PRAP1,CALY,ECHS1,CYP2E1, 
SPRN,PAOX,MTG1,LOC619207 Chr10 675 0.0148 
PCDH15 Chr10 278 0.0002 
KIAA1217 Chr10 121 0.0039 
BLOC1S2,SCD,PKD2L1,CWF19L1 Chr10 510 0.0075 
ATRNL1 Chr10 586 0.0185 
No genes in this region Chr11 486 0.0166 
APLNR,LRRC55 Chr11 283 0.0183 
TTC17,API5 Chr11 216 0.0149 
No genes in this region Chr11 126 0.0016 
QSER1,DEPDC7,PRRG4 Chr11 164 0.0089 
P2RX3,PRG3,SLC43A3,RTN4RL2,SSRP1, 
TNKS1BP1,PRG2 Chr11 284 0.0101 
NOX4 Chr11 444 0.0170 
GYS2,LDHB Chr12 108 0.0081 
No genes in this region Chr12 364 0.0104 
KITLG Chr12 437 0.0006 
SOX5 Chr12 122 0.0108 
BCL2L14,LOH12CR2,LRP6,MANSC1 Chr12 61 0.0028 
SOX5,C12orf67 Chr12 123 0.0198 
ETNK1 Chr12 113 0.0039 
ANKS1B Chr12 489 0.0173 
PZP,LOC642846 Chr12 46 0.0107 
No genes in this region Chr12 362 0.0085 
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No genes in this region Chr13 336 0.0120 
No genes in this region Chr13 371 0.0080 
No genes in this region Chr13 325 0.0048 
SLITRK6 Chr13 426 0.0147 
No genes in this region Chr13 357 0.0184 
KLF12 Chr13 367 0.0019 
No genes in this region Chr14 434 0.0043 
SYT16,FLJ43390 Chr14 308 0.0160 
No genes in this region Chr14 221 0.0110 
ERH,SLC39A9,GALNTL1 Chr14 344 0.0151 
RTN1,GPR135,C14orf149,C14orf100 Chr14 295 0.0089 
SV2B Chr15 447 0.0161 
LBXCOR1,MAP2K5 Chr15 329 0.0018 
SH2D7,CIB2,TBC1D2B Chr15 380 0.0139 
RGMA,CHD2 Chr15 456 0.0036 
PRDM7,GAS8,DBNDD1,C16orf3 Chr16 443 0.0060 
No genes in this region Chr16 321 0.0038 
NMRAL1,CORO7,DNAJA3,C16orf5, 
HMOX2,FAM100A Chr16 22 0.0013 
No genes in this region Chr16 127 0.0176 
BLMH,TMIGD1,CPD Chr17 128 0.0052 
DBF4B,CCDC43,ADAM11 Chr17 200 0.0111 
GHDC,STAT5B,STAT5A,STAT3 Chr17 188 0.0137 
No genes in this region Chr17 336 0.0194 
BLMH,EFCAB5,CCDC55,SLC6A4 Chr17 127 0.0186 
TAF4B,PSMA8 Chr18 110 0.0034 
FAM59A,MEP1B Chr18 140 0.0191 
No genes in this region Chr18 73 0.0084 
No genes in this region Chr18 332 0.0133 
No genes in this region Chr18 89 0.0150 
TCF4 Chr18 256 0.0060 
GALNT13 Chr2 772 0.0073 
CYP20A1,ABI2 Chr2 1019 0.0056 
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GPBAR1,C2orf62,SLC11A1,TMBIM1, 
PNKD,CTDSP1,ARPC2,AAMP,VIL1 Chr2 1094 0.0056 
CCDC148 Chr2 794 0.0195 
No genes in this region Chr2 627 0.0124 
MKI67IP,TSN Chr2 611 0.0145 
No genes in this region Chr2 112 0.0061 
ANKRD44 Chr2 988 0.0085 
No genes in this region Chr2 109 0.0079 
ORMDL1,PMS1,ANKAR,OSGEPL1, 
ASNSD1 Chr2 951 0.0118 
LYPD6 Chr2 749 0.0169 
No genes in this region Chr2 977 0.0177 
MBOAT2 Chr2 45 0.0010 
EFEMP1 Chr2 280 0.0154 
XIRP2 Chr2 837 0.0077 
No genes in this region Chr2 632 0.0119 
VSNL1,SMC6,GEN1 Chr2 88 0.0023 
RHOB Chr2 102 0.0181 
No genes in this region Chr2 286 0.0096 
SULT1C3,SULT1C2,SULT1C4 Chr2 541 0.0105 
ARL6IP6,FMNL2,PRPF40A Chr2 766 0.0130 
EPC2,KIF5C Chr2 746 0.0174 
ASAP2 Chr2 46 0.0078 
No genes in this region Chr2 84 0.0180 
RAPH1,ABI2 Chr2 1020 0.0117 
FOXA2 Chr20 112 0.0099 
PARD6B,ADNP,BCAS4,DPM1 Chr20 244 0.0168 
LOC100130264,SLC24A3 Chr20 95 0.0068 
FAM83C,EIF6,UQCC,PROCR,MMP24 Chr20 166 0.0019 
SCAND1,PHF20,EPB41L1,C20orf152 Chr20 170 0.0024 
DHX35,FAM83D Chr20 185 0.0143 
UQCC,GDF5,CEP250,ERGIC3 Chr20 167 0.0022 
C21orf33,AGPAT3,TRAPPC10,PWP2 Chr21 221 0.0172 
C21orf7,BACH1 Chr21 147 0.0128 
C21orf34 Chr21 81 0.0041 
APOL4,APOL2,APOL3,APOL1 Chr22 174 0.0172 
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PPARA,C22orf26 Chr22 224 0.0092 
PLXNB1,CCDC51,ATRIP,TREX1,PFKFB4, 
FBXW12,UCN2,CCDC72,SHISA5,COL7A1 Chr3 242 0.0031 
OTOL1 Chr3 813 0.0126 
NAALADL2 Chr3 883 0.0101 
MORC1 Chr3 551 0.0121 
PA2G4P4,LEKR1 Chr3 790 0.0146 
ABHD5,ANO10 Chr3 218 0.0153 
SLC15A2,EAF2,ILDR1,IQCB1 Chr3 615 0.0068 
No genes in this region Chr3 374 0.0064 
FLJ46210,LOC389151,LOC729627 Chr3 701 0.0125 
SLC25A26,LRIG1 Chr3 332 0.0157 
ZBTB20 Chr3 578 0.0155 
TIPARP Chr3 789 0.0130 
No genes in this region Chr3 220 0.0055 
PPARG,TSEN2,MKRN2 Chr3 62 0.0178 
WDR49,SERPINI1,PDCD10 Chr3 844 0.0196 
FSTL1,NDUFB4 Chr3 608 0.0162 
EPHA6 Chr3 490 0.0168 
No genes in this region Chr3 839 0.0015 
No genes in this region Chr3 695 0.0062 
CADPS Chr3 313 0.0047 
ZBTB20 Chr3 579 0.0037 
PAK2,SENP5,PIGZ,LOC152217,NCBP2 Chr3 990 0.0131 
No genes in this region Chr3 219 0.0014 
FOXP1 Chr3 357 0.0193 
MAGI1 Chr3 327 0.0114 
DPPA2,DPPA4 Chr3 552 0.0082 
INPP4B Chr4 718 0.0175 
TRPC3,BBS7 Chr4 615 0.0029 
GRSF1,MOBKL1A,RUFY3 Chr4 359 0.0193 
GAB1 Chr4 722 0.0192 
No genes in this region Chr4 492 0.0064 
TMEM155,EXOSC9,CCNA2,ANXA5, 
LOC100192379,BBS7 Chr4 614 0.0044 
No genes in this region Chr4 742 0.0114 
KCNIP4 Chr4 106 0.0058 
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No genes in this region Chr4 795 0.0134 
GRID2 Chr4 468 0.0003 
No genes in this region Chr4 171 0.0158 
RAPGEF2 Chr4 802 0.0005 
No genes in this region Chr4 172 0.0190 
No genes in this region Chr4 140 0.0136 
SCRG1,SAP30,GALNT7,HMGB2 Chr4 872 0.0087 
USP38 Chr4 721 0.0025 
No genes in this region Chr4 803 0.0004 
No genes in this region Chr4 526 0.0011 
GRID2 Chr4 469 0.0032 
CPEB2 Chr4 73 0.0072 
INPP4B Chr4 719 0.0053 
SLIT2 Chr4 99 0.0086 
No genes in this region Chr4 593 0.0103 
CXCL5,CXCL3,PPBP,CXCL2,PF4 Chr4 375 0.0189 
NCRNA00099,KCNIP4 Chr4 107 0.0007 
EDNRA,TMEM184C,LOC90826 Chr4 743 0.0118 
No genes in this region Chr4 170 0.0067 
MARCH11 Chr5 81 0.0093 
PDE4D Chr5 294 0.0122 
RNF180 Chr5 318 0.0188 
RASA1 Chr5 432 0.0033 
HAVCR1,TIMD4,PPP1R2P3 Chr5 781 0.0043 
MCC Chr5 562 0.0027 
No genes in this region Chr5 823 0.0021 
MCC,YTHDC2 Chr5 564 0.0050 
No genes in this region Chr5 485 0.0123 
CCT5,FAM173B,CMBL Chr5 51 0.0065 
No genes in this region Chr5 586 0.0100 
APC,SRP19,MCC,REEP5,DCP2 Chr5 561 0.0035 
No genes in this region Chr5 588 0.0002 
ADAMTS6 Chr5 323 0.0155 
CLINT1 Chr5 786 0.0045 
No genes in this region Chr5 680 0.0110 
CDH9 Chr5 135 0.0197 
No genes in this region Chr5 585 0.0147 
ZNF131,HMGCS1,MGC42105 Chr5 216 0.0156 
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HCP5,MICA,HLA-B,MICB,HCG26 Chr6 157 0.0074 
COL21A1 Chr6 281 0.0126 
No genes in this region Chr6 629 0.0113 
No genes in this region Chr6 417 0.0027 
HMGN3 Chr6 400 0.0199 
BMP5 Chr6 278 0.0144 
ASF1A,FAM184A,MCM9 Chr6 596 0.0030 
No genes in this region Chr6 416 0.0127 
CDYL,RPP40 Chr6 24 0.0066 
GABRR1,PNRC1,SRrp35,PM20D2 Chr6 449 0.0069 
SOBP,SCML4 Chr6 540 0.0180 
PHACTR1 Chr6 65 0.0052 
OPN5,C6orf138 Chr6 239 0.0152 
CD2AP,GPR111,GPR115 Chr6 238 0.0010 
PRIM2 Chr6 286 0.0017 
No genes in this region Chr6 521 0.0163 
GCNT2 Chr6 53 0.0088 
PRIM2 Chr6 287 0.0006 
PKHD1 Chr6 258 0.0182 
No genes in this region Chr7 677 0.0138 
NRF1 Chr7 645 0.0164 
TRPV6,C7orf34,EPHB6,KEL,TRPV5 Chr7 711 0.0054 
ZNF800 Chr7 634 0.0023 
GUSB,VKORC1L1,ASL Chr7 325 0.0057 
ZPBP Chr7 250 0.0014 
PRSS1,TRY6,PRSS2 Chr7 710 0.0040 
No genes in this region Chr7 99 0.0102 
No genes in this region Chr7 425 0.0165 
SDK1 Chr7 20 0.0109 
GCC1,FSCN3,ARF5,PAX4,SND1 Chr7 635 0.0081 
LOC401397,GPR85 Chr7 562 0.0059 
EXOC4 Chr7 664 0.0139 
No genes in this region Chr7 274 0.0129 
IFRD1,C7orf53 Chr7 559 0.0077 
C7orf58,FAM3C,WNT16 Chr7 603 0.0106 
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No genes in this region Chr8 247 0.0046 
No genes in this region Chr8 103 0.0184 
No genes in this region Chr8 385 0.0048 
No genes in this region Chr8 634 0.0097 
No genes in this region Chr8 384 0.0031 
No genes in this region Chr8 246 0.0049 
No genes in this region Chr8 102 0.0140 
HNF4G Chr8 383 0.0112 
CHRNA6,CHRNB3 Chr8 213 0.0132 
MAMDC2 Chr9 359 0.0116 
LINGO2 Chr9 139 0.0171 
SDCCAG3,C9orf163,SNAPC4,SEC16A, 
PMPCA,NOTCH1,INPP5E Chr9 692 0.0076 
NXNL2,SPIN1 Chr9 451 0.0167 
WNK2,C9orf129 Chr9 475 0.0179 
HSPA5,GAPVD1,RABEPK Chr9 635 0.0188 
 
Appendix A lists genes and identified in the top two present of genomic regions by XP-EHH and 
iHS selection scans in the Maduo Tibetan population.   
